Примечания
1
Plant, Jane and Tidey, Gill, 2002. The Plant Programme. Paperback edition. Virgin Books; Plant, Jane and Tidey, Gill, 2005. Eating for Better Health. Virgin Books.
2
Kradjian, Robert D., 1994. Save Yourself from Breast Cancer. Berkley Publishing.
3
Plant, Jane and Tidey, Gill, 2003. Understanding, Preventing and Overcoming Osteoporosis. Virgin Books.
4
Под хемопревентивным действием понимают способность вещества предупредить развитие рака либо затормозить его. – Примеч. ред.
5
Selected causes of death: by gender and age. Office for National Statistics; General Register Office for Scotland; Northern Ireland Statistics and Research Agency. 1997.
6
Deaths: selected causes (International Classification) and sex, 1971 onwards (England and Wales): Health Statistics Quarterly, 04. 1998
7
http://who-pcc.iarc.fr/
8
Trichopoulos, Dimitrios, Li, Frederick, P., and Hunter, David J, 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80–85.
9
Plant, Jane A. and Moore, P. J., 1979. Geochemical mapping and interpretation in Britain. Phil. Trans. Roy. Soc., London, B288, pp. 95-112.
10
Plant, Jane A., Smith, D., Smith, B. and Williams, L., 2000. Environmental Geochemistry at the Global Scale. Geological Society Special Issue.
11
Dewey, John F., 1999. Geoscientist 9, 6 June, Society Awards, pp. 2–4.
12
Blair's war on cancer is a sham, say top doctors. Independent On Sunday. 14 November 1999.
13
Rennie, J, and Rusting, R., 1996. Making Headway Against Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 56-9.
14
Peto, R. and others, 2000. Smoking, Smoking Cessation and Lung Cancer in the UK since 1950. British Medical Journal, 321, 323-9.
15
Raleigh, V. S., 1999. World Population and Health in Transition. British Medical Journal, 319, 981–984.
16
Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October. See also: Packham, David and Tasker, Mary, 1997. Industry and the academy – a Faustian contract. Industry and Higher Education, April, 85–90.
17
World Health Organization's International Agency for Research on Cancer website: http://who-pcc.iarc.fr/
18
Physicians Committee for Responsible Medicine: PCRM Update of Winter 1991.
19
Cancer Research Campaign Factsheet 6.2, 1996.
20
Уинстон Черчилль был подвержен частым приступам депрессии – пожалуй, самого главного его врага. Безысходная тоска охватывала Черчилля в периоды мучительных, неотвязных кризисов, и тогда ему казалось, что «огромный черный пес», как он говорил, преследует его по пятам. – Примеч. ред.
21
Депрессия – очень распространенное явление: за год о симптомах депрессии сообщают более двух миллионов человек. Если вы страдаете депрессией, постарайтесь разобраться, не вызвана ли она реальными проблемами? В этом случае обратитесь за практической помощью и советом. Гражданское консультационное бюро предоставляет бесплатные советы по финансовым и юридическим вопросам, а «Самаритяне» или ваши друзья помогут разобраться с эмоциональными трудностями и научить с ними справляться. Хорошие советы нередко дает MIND, благотворительная организация, занимающаяся душевным здоровьем. В одной из ее недавних брошюр о депрессии (MIND 1999. Depression – don't let it get you down. MIND and Pharmacy Healthcare; Mind Information, 15–19 Broadway, London E15 4BQ; Pharmacy Healthcare scheme, 1 Lambeth High Street, London SE1 7JN) утверждается, что «таблетки для симптомов, а разговор – для решения проблем». Вы должны питаться качественной, разнообразной пищей, поскольку в ней нуждается мозг, не употреблять искусственные органофосфаты (см. главу 6) и алкоголь в больших количествах. Если у вас серьезная депрессия, обратитесь за медицинской помощью. Хотя у современных антидепрессантов есть побочные эффекты, лучше иметь их, чем страдать от тяжелой депрессии.
22
The Times, 7 February 1998.
23
Cox, Peter and Brusseau, Peggy, 1992. Superliving: A Beginner's Guide to Medspeak, Vermillion.
24
Скрининг (от англ. screening, «просеивание») – общее название методов специальных проверок, обследований, применяемых в медицине, биохимии, а также в бизнесе и т. п. В медицине под скринингом понимают проведение простых и безопасных исследований больших групп населения с целью выделения групп риска развития той или иной патологии. – Примеч. ред.
25
Boots the Chemist, 1998. Breast Awareness – an essential guide. Be enlightened, not frightened. Published in association with the charity Breast Cancer Care.
26
Sunday Correspondent, 26 November 1989.
27
Alternative Therapy, British Medical Association, 1986.
28
New Scientist, 27 August 1987.
29
Vickers, A. and Zollman, C., 1999. ABC of complementary medicine: Acupuncture. British Medical Journal, 9 October, 973–976.
30
Дополнительную информацию о контроле боли при раке, в том числе на поздних стадиях, см. в статье Кэтлин М. Фоли в Scientific American, сентябрь, 1996.
31
Gerson, M., 1958. A Cancer Therapy: Results of Fifty Cases, Gerson Institute, California. Forbes, Alec, 1984. The Bristol Diet, Century.
32
Greenwald, P., 1996. Chemoprevention of Cancer. Scientific American, Special issue: What you need to know about Cancer, vol. 275, 3, pp. 96-100; and see also the World Health Organisation's International Agency for Research on Cancer website; http://who-pcc.iarc.fr/ and see also the British National Formulary, 1998.
33
Section on cytotoxic (cell poisoning) drugs in the British National Formularv, 1998.
34
Weinberg, Robert A., 1996. How Cancer Arises. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 62–70.
35
Pollack, M. N. and others, 1998. IGF-1 Risk Factor for Prostate Cancer. Science, 279, 563–566. Pollack, M. N., Huynh, H. T., and Lefebvre, S. P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br. Cancer Res. Treat, 22, 91-100. Pollack, M. N., Polychronakos, C., Yousefi, S., and Richard, M., 1988. Characterisation of insulin-like growth factor-1 (IGF-1) receptors of human breast cancer cells. Biochem Biophy Res. Commun, 154, 1, 326–331.
36
Oliff, Alien, Gibbs, Jackson, B. and McCormick, Frank, 1996. New Molecular Targets for Cancer Therapy. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 144–149.
37
Weinberg, Robert A., 1996, How Cancer Arises. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 62–70.
38
Jain, R. K., 1994. Barriers to Drug Delivery in Solid Tumours. Scientific American, July, 271 (l), pp. 58–65.
39
Trichopoulos, Dimitros, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer. September 275, 3, 80–85.
40
Boots the Chemist, 1998. Breast Awareness – an essential guide, Be enlightened, not frightened. Published in association with the charity Breast Cancer Care.
41
Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer Scientific American, Special Issue, What you need to know about Cancer. September, 275, 3, 80–85.
42
Holland, J. C., 1996. Cancer's Psychological Challenges. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 158–161.
43
http://www.who.int/nut/malnutrition_worldwide.htm
44
Cancer Incidence in Five Continents, 1997. Vol VII, published by the IARC (International Agency for Research on Cancer).
45
Cancer Incidence in Five Continents. 1997. Vol. VII, published by the IARC (International Agency for Research on Cancer).
46
Kliewer, E. V. and Smith, K. R., 1995. Breast cancer mortality among immigrants in Australia and Canada. Journal of Natl Cancer Institute, 87, 15, 1154–1161. See also Cancer Research Campaign, 1996, Factsheet 6.2, Breast Cancer – UK.
47
Campbell, T. C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. Am. J. Clin. Nutr., 59, Suppl., 11 535-11 615,
48
Rohan, T. E., McMichael, A. J. and Bagbursi, P. A., 1988. A population-based case control study of diet and breast cancer in Australia. Am. J. Epidemic, 128, 478–489; Howe, G. R., Hirobata, T., Hislap, T. G. and others. 1990. Dietary factors and risk of breast cancer, combined analysis of 12 case-control studies. J. Natl Cancer Inst., 8, 561–569; Willet, Walter C. and others, 1987. Dietary fat and the risk of breast cancer. N. Engl J. Med., 316, 22–28; Jones, D. Y., Schatzkin, A., Green, S. B. and others. 1987. Dietary fat and breast cancer in the National Health and Nutrition Examination Survey epidemiological follow-up study. J. Natl Cancer Inst., 79, 465–471.
49
Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80–85.
50
Cramer, D. W. and others, 1989. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet, 2, 66–71.
51
Stocks, P., 1970. Breast cancer anomalies. British Journal of Cancer, 24, 633–643.
52
Maruchi, N. and others, 1977. Relation of food consumption to cancer mortality in Japan, with special reference to international figures. Gann, 1977; 68, 1-13.
53
Cox, Peter and Brusseau, Peggy, 1995. Life Points For Kids. Bloomsbury.
54
Statistical Abstracts of the US, 1994 edition.
55
Willett, W. C. and others, 1996. Strategies for Minimizing Cancer Risk. Scientific American, Special Issue, What you need to know about Cancer, 275:3, pp, 88–95.
56
Akre, James, ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol. 67, and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.
57
Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.
58
Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.
59
Akre, James, Ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol. 67; and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.
60
Akre, James, Ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol 67, and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.
61
Akre, James Ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol. 67, and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.
62
American Academy of Pediatrics Committee on Nutrition (1992). The use of whole cows' milk in infancy. Pediatrics, 89, 1105–1109.
63
Anyon, C. P. and Clarkson, K. G., 1971. A cause of iron-deficiency anaemia in infants. N. Z. Med. J., 74, 24–25.
64
Clyne, P. S. and Kulczycki, A. 1991. Human breast milk contains bovine IgG. Relationship to infant colic? Pediatrics, 87(4), 439–444. Wilson, J. F., Lahey, M. E. and Heiner, D. C., 1974. Studies on iron metabolism. Further observations on cow's milk-induced gastrointestinal bleeding in infants with iron-deficiency anaemia. J. Pediatr., 84, 335–344.
65
Pugh, R. H., 1981. Allergy to Cows' Milk Protein. Health Visitor, Vol. 54, 231–233.
66
Scon, F. W., 1990. Cow milk and insulin-dependent diabetes mellitus: is there a relationship? Am. J. Clin. Nutr., 51, 489–491.
67
Bahna, S. L., 1987. Milk allergy in infancy. Ann Allergy, 59, 131.
68
Dunea, G., 1982. Beyond the Etheric. Br. Med. J., 285, 428–429.
69
Kretchmer, N., 1981. The Significance of lactose intolerance. In: Paige, D. M. and Bayless, T. M., Eds., Lactose Digestion: Clinical and nutritional implications, Johns Hopkins University Press.
70
Chiodini, R. J. and Hermon-Taylor, J., 1993. The thermal resistance of Mycobacterium paratuberculosis in raw milk under conditions simulating pasteurisation. J. Vet. Diagn. Invest., 5, 629–631 and Grant, I. R., Ball, H. J., and Rowe, M. T., 1996. Inactivation of Mycobacterium paratuberculosis in cows' milk at pasteurisation temperatures. Appl. And Env. Microbiology, 62, 631–636.
71
The Institute of Food Science & Technology Position Statement, 1998. Food Science Of Technology Today. 12 (4), 223–228, September, http://www.ifst.org/hottop23.html
72
Financial Times for the weekend 20–21 November 1999.
73
The Institute of Food Science & Technology Position Statement. http://www.ifst.org/hottop2.html. Hard copies available from IFST, 5 Cambridge Court, 210 Shepherds Bush Road, London, W6 7NJ.
74
EU Directive 70/524 February 1999.
75
US FDA websites: http://vm.cfsan.fda.gov/~ear/m190-11.html; http://vm.cfsan.fda.gov/~ear/
76
Ingersoll, Bruce, 1990. Technology and Health: FDA Detects Drugs in Milk but Fails to Confirm Results. Wall Street Journal, 6 February p. 86; Ingersoll, Bruce, 1990. Politics and Policy: GAO Says FDA Can't Substantiate Claims About Milk. Wall Street Journal, 21 November p. A16; and Ingersoll, Bruce, 1990. Technology & Health: FDA Plans a Nationwide Test of Milk for Antibiotics, Other Drug Residues. Wall Street Journal, 28 December p. 10.
77
European Commission, Scientific Committee on Veterinary Measures relating to Public Health, 1999. Report on Public Health Aspects of the Use of Bovine Somatotropin, 15–16 March.
78
Cutwater, J. L. and others, 1997. Dairy Products and Breast Cancer: the IGF-1, estrogen and bGH hypothesis, Medical Hypotheses, 48, 453–461.
79
ДДТ (дихлордифенилтрихлорэтан) – один из самых известных пестицидов.
80
The Guardian, 13 July 1999.
81
McCusker, R. H., 1998. Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding. J. Dairy Sci., 81, 1790–1800.
82
Гормон роста, или соматотропин, структурно различается у разных видов животных, поэтому его называют согласно виду, которому он принадлежит, – бычий, свиной или, например, человеческий.
83
The Institute of Food Science & Technology Position Statement http://www.easynet.co.uk/ifst/hottop8a.htm
84
Eppard, P. J. and others, 1985. Effect of dose of bovine growth hormone on milk consumption: alpha-lactalbumin, fatty acids and mineral elements. J. Dairy Science Vol. 68 (11), pp. 3047–3054. See also Cohick, W. S. and others, 1992. Regulation of insulin-like growth factor-binding proteins in serum and lymph of lactating cows by somatotropin. Endocrinology, 130(3), pp. 1508–1514.
85
Mepham, T. B. and others, 1994. Safety of Milk from Cows Treated with Bovine Somatotropin. Lancet, 334, November 19, 1445–1446 and Mepham, T. B. and Schonfield, P. N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.
86
Simpson and others, http://www.nal.usda.gov/ttic/tekran/glimpse/data/000007/75/0000077539.html
87
Miller, M. A., Hildebrand, J. R., White, T. C., Hammond, E. G., Madson, K. S., and Collier, R. J., 1989. Determination of insulin-like growth factor-1 (IGF-1) concentrations in raw pasteurised and heat treated milk. Journal of Dairy Science, 72, Supplement 1, 186–187.
88
Hankinson, Susan E. and others, 1998. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351, 9113, 9 May, 1393–1396.
89
Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk; A Prospective Study. Science, 279, January.
90
Pollack, M. N., Huynh, H. T. and Lefebvre, S. P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br. Cancer Res. Treat, 22, 91-100.
91
Pollack, M. N. and others, 1998. IGF-1 Risk Factor for Prostate Cancer. Science, 279, 563–566.
92
Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk: A Prospective Study. Science, 279, January.
93
Holly, Jeff, 1998. Insulin-like growth factor-1 and new opportunities for cancer prevention. Lancet, 351, 9113, 9 May, 1373–1375.
94
Epstein, Samuel S., 1996. Unlabelled Milk from Cows Treated with Biosynthetic Growth Hormones: A Case of Regulatory Abdication. International Journal of Health Services, 26, 1, 173–185.
95
Outwater, J. L., Nicholson A. and Bernard N., 1997. Dairy products and breast cancer: the IGF-1, estrogen, and bGH hypothesis. Medical Hypotheses 48, 453–461.
96
Leonard, Rodney E., 1995. Codex at the Crossroads: Conflict on Trade Health. Nutrition Week, Vol. 25, № 26, 14 July, pp. 4–5, Nutrition Week is published by the Community Nutrition Institute, 910 17th Street, N. W., Suite 413, Washington DC 20006.
97
The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions. http://europa.eu.mt/comm/dg24/health/sc/scv/out19_en.html
98
D'Ercole, J. A., Underwood, L. E. and Van Wyk, J. J., 1977. Serum Somatomedin-C in hypopituaritism and in other disorders of growth. J. Pediatr., 90, 3, 375–381. See also Cullen, K. J. and others, 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research, vol. 50, pp. 48–53.
99
De Leon, D. D., Wilson, D. M., Powers, M. and Rosenfeld, R. G., 1992. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors, 6, 327–336.
100
Peyrat, J. P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur. J. Cancer, 29A, 4, 492–497.
101
Peyrat, J. P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur. J. Cancer, 29A, 4, 492–497.
102
Musgrove, E. A. and Sutherland, R. I., 1993. Acute effects of growth factors on T471 breast cancer cell cycle progression, Eur. J. Cancer, 29A, 16, 2273–2279.
103
Heldrin, C. N. and Westermark, B., 1984. Growth factors: mechanism of action and relation to oncogenes. Cell, 37:9, 20.
104
Macaulay, V. M., 1992. Insulin-like growth factors and cancer. Br. J. Cancer, 65, 311–320.
105
Underwood, L. E., D'Ercole, J. A. and Van Wyk, J. J., 1980. Somatomedin-C and the assessment of growth. Ped. Clin. N. Amer., 27, 4, 771–782, and Perdue, J. F., 1984. Chemistry, structure and function of insulin-like growth factors and their receptors: a review. Can J. Biochem Cell Bio., 62, 1237–1245.
106
Outwater, J. L., Nicholson, A, and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.
107
The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions. http://europa.eu.int/comm/dg24/health/sc/scv/out19_en.html
108
Council on Scientific Affairs, American Medical Association, Biotechnology and the American Agricultural Industry, 1991. Journal of the American Medical Association (JAMA), 265, 11, 20 March, p. 1433.
109
Mepham, T. B. and Schonfield, P. N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.
110
Challacombe. D. N. and Wheeler, E. E., 1994. Safety of milk from cows treated with bovine somatotropin. Lancet, 344, 17 September, p. 815.
111
Sell, C., Rubin, R. and Baserga, R., 1995. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Research, Jan 15, 55(2), 303–306.
112
Burton, Jeanne L. and others, 1994. A review of bovine growth hormone, Canadian Journal of Animal Science, 74, 167–201.
113
Xian, C., 1995. Degradation of IGF– 1 in the Adult Rat Gastrointestinal Tract is limited by a Specific Antiserum of the Dietary Protein Casein. Journal of Endocrinology, 146, 2, 1 August, p. 215, and Thornburg, W. and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246, G80-G85.
114
Outwater, J. L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.
115
Harasuchi, S., Good, R. A., Engelman, R. W. and Day, N. K., 1992. Human prolactin regulates transfected MMTV LTR-directed gene expression in a human breast-carcinoma cell line through synergistic interaction with steroid hormones. Int J. Cancer, 52, 923–933.
116
Clevenger, C, V., Chang, W. F., Ngo, W., Pasha, T. L., Montone, K. T. And Tomaszewski, J. E., 1995. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am. J. Pathol., 146, 695–705.
117
Vonderhaar B. K., 1989. Estrogens are not required for prolactin induced growth of MCF-7 human breast cancer cells. Cancer Lett, 47, 105–110.
118
http://www.shef.ac.uk/uni/academic/a-c/csi/1997/pir2.html
119
Lochnan, H. A. and others, 1995. Functional activity of the human prolactin receptor and its ligands. Mol. Cell. Endocrinol, 114, 91–99.
120
http://mammary.nih.20v/reviews/tumorigenesis/Vonderhaar001/slides/introduction.html
121
Struman, I., Bentzien, F., Lee, H., Mainfroid, V., D'Angelo, G., Goffin, V., Weiner, R. I. and Martial, J. A., 1999. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA, 96, 1246–1251.
122
http://www.eurekalert.org/releases/upmc-bcc061699.html
123
Lawrence R., 1994. Breastfeeding – A Guide to the Medical Profession, Fourth edition, Mossby, USA.
124
http://www.inter-medico.com/prolactin.html
125
Lawrence, R., 1994. Breastfeeding: A Guide for the Medical Profession. Fourth edition, Mossby, USA.
126
Poggi, S. H., Skinner, H., Catherine W. and others, 1998. Using scanning electron microscopy to study mineral deposits in breast tissues. American Mineralogist, 83, 1122–1126.
127
Lee, J. R., 1996. Natural Progesterone. John Carpenter Publishing, Oxfordshire, 113 pp.
128
Wolford, S. T. and Argoudelis, C. J., 1979. Measurement of Estrogens in Cow's Milk, Human Milk and Dairy Products. J. Dairy Sci., 62(9), 1458–1463.
129
Outwater, J. L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.
130
The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating to Public Health – Outcome of discussions. 1999, Report on Public Health Aspects of the Use of Bovine Somarotropin. http://europa.eu.int/comm/dg24/health/sc/scv/out19_en.html
131
Allen, N. E., and others, 2000. Hormones and Diet: Low Insulin-like Growth Factor-1 but Normal Bioavailable Androgens in Vegan Men. Brit. J. Cane., 83 (1), 95–97.
132
Веганство (веганизм, англ. Veganism) – наиболее последовательная форма вегетарианства, строго вегетарианский образ жизни, исключающий использование продуктов, связанных с эксплуатацией и убийством животных. Веганы – строгие вегетарианцы, исключающие из своего рациона все продукты животного происхождения, включая мясо, рыбу, яйца, молоко, молочные продукты и иногда мед. Веганы не используют мех и кожу животных, выступают против убийства животных ради опытов и развлечений. – Примеч. ред.
133
Chan, J. C., and others, 1998. Plasma TGF-1 and Prostate Cancer Risk: A Prospective Study. Science 279, January.
134
Kradjian, R. D., 1994. Save Yourself from Breast Cancer, Berkley Books, New York.
135
Кормовая патока, побочный продукт сахарного производства; сиропообразная жидкость темно-бурого цвета со специфическим запахом. В США и Канаде используется в кулинарии как сироп. – Примеч. ред.
136
Wright, K., 1996. A plea for prevention. Scientific American, September. (Inset p.99 in article by Greenwald 1996, see below ref. 20).
137
Collaborative Group on Hormonal Factors in Breast Cancer, 1996. Lancet, 347, 1713–1727.
138
http://www.who.int/nut/malnutrition_worldwide.html
139
The Times, 2 November 1999.
140
Riggs, B. L., Wahner, H. W., Melton, L. J. 3rd, Richelson, L. S., Judd, H. L. And O'Fallon, W. M., 1987. Dietary calcium intake and rates of bone loss in women. J. Clin. Invest., Oct, 80, 4, pp. 979–982.
141
Hegsted, D. M., 1986. Calcium and Osteoporosis. J. Nutr., 116, 2316–2319.
142
Kim, J. B., 1990. Fractured truths. Bestways v 18, n2, p. 26(7).
143
Kim, J. B., 1990. Fractured truths. Bestways v 18, n2, p. 26(7).
144
http://www.who.int/nut/malnutrition_worldwide.html
145
Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Department of Health, 1991.
146
Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Department of Health, 1991. P. 139, table 22.2.
147
Havaia, S. and Dwyer, J., 1988. Position of the American Dietetic Association: Vegetarian Diets – technical support paper. J. Am. Diet Assoc, 88:3 352–355.
148
Barnard, N., 1993. Food for life, Harmony Books.
149
'Research Advances in Osteoporosis', 1990. Conference by the National Osteoporosis Foundation, the National Institutes of Health, and the American Society of Bone and Mineral Research, Arlington, Virginia, USA February.
150
Heaney, R. P. and Weaver, C. M., 1990. Calcium absorbability from kale. Am. J. Clin. Nutr., 51, 656–657.
151
Breslau, N. A., Brinkley, L., Hill, K. D. and Pak, C. Y., 1988. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J. Clin. Endocrinol. Metab., Jan, 66, 1, pp. 140–146.
152
Heaney, R. P. and Recker, R. R., 1982. Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J. Lab. Clin. Mod., Jan, 99, 1, pp. 46–55.
153
Pritchard, K. I. and others, 1996. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer, Journal of Clinical Oncology, vol. 14 (10), 2731–2738.
154
Gooderham, M. J., Adlercreutz, H., Sirpa, T. O., Wahala, K. and Holub, B. J., 1996. A Soy Protein Isolate Rich in Genistein and Daidzein and its Effects on Plasma Isoflavone Concentrations, Platelet Aggregation, Blood Lipids and Fatty Acid Composition of Plasma Phospholipid in Normal Men. J. Nutr., 126, 2000–2006.
155
Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96–99.
156
Kurzer, M. S. and Xu, X., 1999. Dietary Phytoestrogens. Annual Reviews of Nutrition, Vol. 17, pp. 353–381.
157
Shurtleff, William and Aoyagi, Akiko, 1975. The Book: of Tofu. Autumn Press Inc.
158
Kurzer, M. S. and Xu, X., 1999, Dietary Phytoestrogens. Annual Reviews of Nutrition Vol. 17, pp. 353–381.
159
UK Ministry of Agriculture, Fisheries and Food advice as reported in the Sunday Times, 1999.
160
Willet W. C., 1994. Micronutrients and cancer risk. Am. J. Clin. Nutr., 59, (suppl), 116 2S-5S. See also: Willett, Walter C., Colditz, Graham A. and Mueller, Nancy A., 1996, Strategies for Minimising Cancer Risk. Scientific American, Special Issue, «What you need to know about Cancer, September», 275, 3, 88–95.
161
Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96–99.
162
Levy, J., Bosin, E., Feldman, B., Giat, Y., Milnster, Danilenko, M. and Sharoni, Y., 1995. Lycopene is more potent inhibitor of human cancer cell proliferation than either A-carotene or B-carotene. Nutr. Cancer, 24, 257–266.
163
Nagasawa, H., Mitamura, T., Sakamoto, S, and Yamamoto, K., 1995. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res. 15, 1173–1178.
164
Willett, Walter C., Colditz, Graham A. and Mueller, Nancy A., 1996. Strategies for Minimising Cancer Risk. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 88–95.
165
Ortega, R. M. and others, 1996. Functional and Psychic Deterioration in Elderly People may be aggravated by folate deficiency. J. Nutr., 126, 1992–1999.
166
Phipps, W. R., Martini, M. C., Lampe, J. W., Slavin, J. L. and Kurzer, M. S., 1993. Effect of fl ax seed ingestion on the menstrual cycle. J. Clin. Endocrinol. Metab., 77, 5, November, 1215–1219.
167
www.flax.com.fda
168
Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96–99.
169
Coghlan, Andy, 1999. Crunch Time for Cancer. New Scientist, 13 November, 264, 2212.
170
Pinto, J. T., Qiao, C. H., Xing, J., Rivlin, R. S., Protomastro, M. L., Weissler, M. L. and Hesion, W. D. W., 1999. Effects of garlic thioallylic derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture. Am. J. Clin. Nutr. See also: Li, G., Qiao, C. H., Lin, R. I., Pinto, J., Osborne, M. F., and Tiwari, R. K., 1995, Antiproliferative effects of garlic constituents in cultured human breast cancer cells. Oncology Rpts., 2, 787–791.
171
www.3mistral.co.uk/garlic/cancer.htm; www.mskcc.org/rande/pharmacology/189.html
172
Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96–99.
173
Doll, R. and Peto, R., 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. New York: Oxford University Press.
174
Lang, T. and Clutterbuck, C., 1991. P is for Pesticides, Ebury Press, Random Century Group, 256 p.
175
McMichael, A. J., 1993. Planetary Overload – Global Environmental Change and the Health of the Species. Cambridge University Press.
176
Lang, T. and Clutterbuck, C., 1991. P is for Pesticides, Ebury Press, Random Century Group, 256 p.
177
http://www.radian.com/standards; http://ro-systemsnet/atrazine.html
178
Stevens and others, 1994. http://www-oem.ucdavis.edu~beaumont/Agrichem/herbicides/triazine/triazine.html Stevens, J. T. and Sumner, D. D., 1991. Herbicides, in Handbook of Pesticide Toxicology, Vol. 3. Classes of Pesticides, Toronto: Academic Press Inc, 1317–1408. See also Environmental Endocrine Disrupters: A handbook of property data, 1999.
179
http://who-pcc.iarc.fr/
180
Hambridge, K. M., Casey, C. E. and Krebs, N. F., 1986, Zinc, In: Trace Elements in Human and Animal Nutrition, Fifth Edition, Mertz, W., Ed. Academic Press, Inc, London.
181
McCusker, R. H., 1998. Controlling Insulin-Like Growth Factor Activity and the Modulation of Insulin-Like Growth Factor Binding Protein and Receptor Binding. J. Dairy Sci, 81, 1790–1800.
182
Simpson and others. Effect of exogenous estradiol on plasma concentrations of somatotropin, insulin-like growth factor 1, insulin-tike growth factor-binding protein activity and metabolites in ovariectomised Angus and Brahman cows. http://www.nal.usda.gov/ttic/tektran/glimpse/data/000007/75/0000077539.html
183
The Globe and Mail 31 July 1999.
184
Hendler, S. S., 1990. The Doctors' Vitamin and Mineral Encyclopedia, Simon and Schuster, New York.
185
Эстуарий – географический и геологический термин для обозначения сильно расширенного устья реки. – Примеч. ред.
186
Hetzel, B. S., and Maberly, G. E., 1986. Iodine, In: Trace Elements in Human and Animal Nutrition, Fifth Edition, Mertz, W., Ed. Academic Press, Inc, London.
187
Eskin, B. A., Shuman, R., Krouse, T., Merion, J. A., 1976. Rat mammary glandatypia produced by iodine blockade with perchlorate. Cancer Res, 35(9), 2332–2339. See also Eskin, B. A., 1978. In: Inorganic and Nutritional Aspects of Cancer. Schrauzer, G. N., ed., 293–304, Plenum Press, New York. This reference is quoted in Grouse, Robert G., Pories, Walter J., Bray, John T. and Mauger, Richard L., 1983. Geochemistry and Man: Health and Disease 1. Essential Elements. In: Applied Environmental Geochemistry. Thomton, I., Ed. London, Academic Press, 267–308.
188
Johnson, C., 1999, Environmental controls in iodine deficiency disorders (TDD), Earthworks, 9 November, p. 3, British Geological Survey.
189
Simopoulos, A. P., 1991. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr., 54, 438–463.
190
Simopoulos, A. P., 1991. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr., 54, 438–463. See also Fernandes, G. and Venkatraman, J. T., 1993. Role of omega-3 fatty acids in health and disease. Nutr. Res., 13, S19-S45.
191
Reported in the London Evening Standard, 17 March 1989. See also Willer W. C., 1994, Micronutrients and cancer risk. Am. J. Clin. Nutr., 59, (suppl), 1162S-1165S.
192
Hunter, David J. and Willett, Walter C., 1993. Diet and Body Build: Diet, Body Size and Breast Cancer, Epidemiologic Reviews, 15, 1, 110–132.
193
Ingram, A. J. and others, 1995. Effects of a Flaxseed and Flax Oil Diet in a Rat – 5/6 Renal Ablation Model. American Journal of Kidney Disease, February 25, 2, 320–329.
194
Obermeyer, W. R., Musser, S. M., Betz, J. M., Casey, R. E., Pohland, A. E. and Page, S. W., 1995. Chemical studies of phytoestrogens and related compounds in dietary supplements – fl ax and chaparral. Proceedings of the Society for Experimental Biology and Medicine. See also Obermeyer, W. R., Warner, C., Casey, R. E. and Musser, S., 1993, Flax seed lignans isolation metabolism and biological effects. Fed. Am. Soc. Exp. Biol. J., A863.
195
Dupont, J., White, P. J., Johnston, K. M. and others, 1989. Food safety and health effects of canola oil. J. Am. Coll. Nutr., 8, 360–375.
196
Kohlmeier, L, and others, 1997. Adipose tissue trans fatty acids and breast cancer in the European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer, Cancer Epidemiol. Biomarkers prev., 6, 9, 705–710.
197
Koletzko, B., 1992. Trans fatty acids may impair biosynthesis of long-chain polyunsaturates and growth in man. Acta Paediatr., 81, 302–306.
198
Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J, 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80–85.
199
Forbes, Alec, 1984. The Bristol Diet, Century.
200
Ingram, A. J., Parbtani, A., Clark, W. F, Spanner, E., Huff, M. W., Philbrick, D. J. and Holub, B. J., 1995. Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model. Am. J. Kidney Dis., February, 25, 2, 320–329.
201
Lee, S. and others, 1999. Monitoring of Drinking Water in terms of Natural Organic Matter and Disinfection By-products. Proc. 2nd Intern. Symp. On Advanced Env. Monitoring, Kwangju, Korea.
202
Herrick, D., 1996. Cryptosporidium and Giardia: Should you be concerned? Water Well Journal, 50, 4, 49, 44–46.
203
Jankun, Jerzy, Seiman, Steven H., Swiercz; Rafal and Skrzypczak-Jankun, Ewa, 1997. Why drinking green tea could prevent cancer. Nature, 387, 15 June, p. 561 see also: Greenwald, Peter, 1996. Chemoprevention of Cancer, Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96–99.
204
Jankun, Jerzy, Selman, Steven H., Swiercz, Rafal and Skrzypczak-Jankun, Ewa, 1997. Why drinking green tea could prevent cancer. Nature, 387, 15 June, p. 561.
205
Campion, K., 1986. Vegetarian Encyclopedia, Century Hutchinson Ltd, London.
206
Jankun, Jerzy, Selman, Steven H., Swiercz, Rafal and Skrzypczak-Jankun, Ewa, 1997. Why drinking green tea could prevent cancer. Nature, 387, 15 June, p. 561.
207
http://research.kib.ki.se/e-uven/public/51419.html
208
Lockwood, K., Moesgaard, S., Hanioka, T. and Fotkers, K., 1994. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol aspects Mod, 15, Suppis, 231–240. Lockwood, K., Moesgaard, S, and Folkers, K., 1994. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochemical and Biophysical Research Communications, 199, 3, March 30, 1504–1508. Lockwood, K., Moesgaard, S., Yamamoto, T. and Folkers, K., 1995. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochemical and Biophysical Research Communications, 212. 1, 172–177.
209
Gerhard Schrauzer, Ph. D., of the University of California cited in Better Nutrition, Nov, 1989, v 51, no. 11, p. 14 (2).
210
Redbook., April, 1989, v 172, n 6, p. 96 (5).
211
Spallholz, J. E., Stewart, J. R., 1989. Advances in the role of minerals in immunobiology. Center for Food and Nutrition, Texas Tech University, Lubbock 79409. Biol Trace Elem Res. Mar, 19 (3) pp. 129–151.
212
Archives of Environmental Health, September/October 1976.
213
Knekt, Paul, and others, 1988. Selenium Deficiency and Increased Risk of Lung Cancer. Abstract of paper read at the Fourth International Symposium on Selenium in Biology and Medicine, Tubingen, West Germany, July.
214
Reinhold, U., and others, 1988. Selenium deficiency and Lethal Skin cancer. Abstract of paper read at the Fourth International Symposium on Selenium in Biology and Medicine, Tubingen, West Germany, July.
215
Lockwood, K., Moesgaard, S., Hanioka, T., and Folkers, K., 1994. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med, 15, Suppls., 231–240. See also: Lockwood, K., Moesgaard, S. and Folkers, K., 1994. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochemical and Biophysical Research Communications, 199, 3, 30 March, 1504–1508. See also: Lockwood, K., Moesgaard, S, Yamamoto, T. and Folkers, K., 1995. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochemical and Biophysical Research Communications, 212, 1, 172–177.
216
Следуйте инструкциям производителя и не превышайте рекомендуемую дозу.
217
Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, 1982. Geneva: World Health Organization, International Agency for Research on Cancer, 1972 – present. (Multivolume work). V29, p. 282. See also Osihi, Shinshi, 1990. Effects of phthalic acid esters on testicular mitochondrial functions in the rat Archives of Toxicology, March, V64 n 2, p. 143 (5).
218
Holland, J. C., 1996. Cancer's Psychological Challenges. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 158–161.
219
Когнитивная терапия – одно из направлений в психотерапии, опирающееся на положение об определяющей роли познавательных процессов (и в первую очередь мышления) в возникновении различного рода психологических проблем и психических отклонений (например, депрессии); бихевиористика – наука о поведении человека. – Примеч. ред.
220
Heason, P., Deep Relaxation available from 37 Tollerton Lane, Tollerton, Nottingham.
221
Based on Holland, J. C., 1996. Cancer's Psychological Challenges. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 158–161.
222
Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80–85.
223
Levy, Len, 1998, Biomed II: Exposure to low-level benzene, p. 76. In: Institute for Environment and Health, Annual Report. 100 pp.
224
Pearson, J. K., 2000. The Air Quality Challenge, American Society of Automotive Engineers and HMSO.
225
Лав Кэнел (Love Canal) – построенное на месте бывшей химической свалки поселение, где обнаружилась повышенная частота врожденных дефектов и хромосомных аномалий; Бхопал – индийский город, в котором в результате аварийного выброса на химическом заводе компании Union Carbide в 1984 году погибло около 3 тысяч человек (и еще около 15 тысяч в последующие годы); Севезо – город на севере Италии, где в 1976 году на заводе ICMESA Женевской косметической фирмы Givaudan произошла взрывоподобная утечка химикатов, что вызвало необходимость массовой эвакуации жителей. – Примеч. ред.
226
North Atlantic Treaty Organisation, 1988. International Toxicity Equivalency Factor (I-TEF) method of risk assessment for complex mixtures of dioxins and related compounds. Pilot study on international information exchange on dioxins and related compounds. CCMS Report Number 176, Environmental Protection Agency, Washington DC, USA. Department of Health, 1995. Statement by the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment on the US EPA draft, health assessment document for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Dept of Health, London.
227
Хлоракне – угреподобное поражение кожи, возникающее после длительного контакта с хлорированными углеводами. – Примеч. ред.
228
EPA Dioxin Reassessment Summary, 1994 4/94 – Vol. 1, CERI/ORD Publication Centre, USEPA.
229
MAFF, 1997. Dioxins and PCBs in retail cows' milk in England. Food Surveillance No. 136, December, Ministry of Agriculture, Fisheries and Food, London.
230
Tanabe, S., 1988. PCB Problems in the Future: Foresight from Current Knowledge. Environmental Pollution, 50, 5-28.
231
Department of the Environment, 1989. Dioxins in the Environment Pollution Paper, No. 27, HMSO, London.
232
MAFF, 1997. Dioxins and Polychlorinated Biphenyls in Fish Oil Dietary Supplements and Licensed Medicines. Food Surveillance Information Sheet, № 106, Ministry of Agriculture, Fisheries and Food, London.
233
MAFF, 1996. Dioxins In Human Milk. Food Surveillance Information Sheet, № 88, Ministry of Agriculture, Fisheries and Food, London.
234
MAFF, 1996. Polychlorinated Biphenyls in Food – UK Dietary Intakes. Food Surveillance Information Sheet, № 89, Ministry of Agriculture, Fisheries and Food, London.
235
Environmental Endocrine Disruptors: A Handbook of Property Data, John Wiley and Sons.
236
Shin, R. J. and others, 1999. Development of a bioassay system for identification of Endocrine Disrupters. Proc. 2nd Intern. Symp. On Advanced Env. Monitoring, Kwangju, Korea.
237
Soto, A. M. and others, 1992. An in culture bioassay to assess the estrogenicity of xenobiotics. In: Chemically-induced alterations in sexual and functional development. The wildlife/ human connection. Vol. 21, Colborn T. C, Clement ed., Princeton Scientific Publishing, 295–309. See also: Soto, A. M. and others, 1995. The E-SCREEN assay as a tool to Identify estrogens: An update on estrogenic environmental pollutants. In: Estrogens in the Environment, Environmental Health Perspectives, 113–122.
238
Davis, Devra Lee, Axelrod, Deborah, Osborne, Michael P. and Telang, Nitin T., 1997. Environmental influences on Breast Cancer Risk, World Resources Institute, Washington, DC, USA, Science and Medicine. May/June.
239
Colborn, T., Dumanoski, D. and Myers, J. P., 1996. Our Stolen Futures, Dutton, Penguin Books, USA.
240
Dyson, T., 1999. Prospects for feeding the world. British Medical Journal, 319, 988–991.
241
Reuters, 8 October 1998.
242
McMurry, Laura M., Oethinger, Margaret, Levy, Stuart B., 1998. Triclosan targets lipid synthesis. Nature, 394, 6693, 531–532.
243
Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J, 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80–85.
244
Campbell, T. C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. Am. J. Clin. Nutr., 59, Suppl., 11 535-11 615.
245
Инвазивная процедура (от invado – «вхожу внутрь») – медицинская процедура, связанная с проникновением через естественные внешние барьеры организма (кожа, слизистые оболочки). Примером простейшей инвазивной процедуры является любая инъекция, самой сложной – хирургическая операция. Инвазивные процедуры могут применяться также для диагностики. – Примеч. ред.
246
Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes. October.
247
Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October.
248
Association of University Teachers. Efficiency Gains or Quality Losses? 1996 (Based on DfEE and Welsh Office figures).
249
Bok, D., 1990. In: Universities and the Future of America , Duke University Press, Durham NC.
250
Glantz, S. A., 1996. Times Higher Education Supplement, 6 September, p. 15. and Glantz, S. A., Slade, J., Bero, L. A., Hanauer, P. and Barnes, D. E., 1996. The Cigarette Papers, University of California Press.
251
Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October. See also: Packham, David and Tasker, Mary, 1997. Industry and the academy – a Faustian contract. Industry and Higher Education, April, 85–90.
252
Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October. See also: Packham, David and Tasker, Mary, 1997. Industry and the academy– a Faustian contract. Industry and Higher Education, April, 85–90.
253
Jasanoff, S., 1997. Civilization and madness: the great BSE scare of 1996. Public Understand. Sci. 6, 221–232.
254
McMichael, A. J. and Powles, J. W., 1999. Human numbers, environment, sustainability and health. British Medical Journal, 319, 9 October, 977–980.
255
www.nlm.nih.gov/medlineplus/ency/article/002919.htm
256
McKenna, Claire, 2002. UK has highest reduction in deaths from lung and breast cancer. BMJ, 325, 63.
257
Irwig, Les, 2006. Evaluating new screening tests for breast cancer. BMJ, 332, 678–679.
258
Anon, 2006. Screening for breast cancer. BMJ, 332, 499–500.
259
www.nlm.nih.gov/medineplus/ency/article/002919.htm
260
e. g. Baum, M., 2000. Survival and reduction in mortality from breast cancer – Impact of mammographic screening is hot clear (Letter). BMJ, 321, 1470.
261
Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.
262
Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.
263
Josefson, Deborah, 2002. Breast self-examination does not improve cancer survival. BMJ, 325, 793.
264
Zackrisson S. and others, 2006. Rare of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial; follow up study. BMJ, 332, 689–692.
265
Anon, 2006. Screening for breast cancer. BMJ, 332, 499–500.
266
Symonds, R. Paul, 2002. Cancer biology may be more important than diagnostic delay. BMJ, 325, 774.
267
Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.
268
www.cancerscreening.nhs.uk/breastscreen
269
White, Caroline, 2002. 'Unacceptable' errors found in breast screening process. BMJ, 324, 933.
270
UK National Radiological Protection Board, www.nrpb.org/radiation_topics/risks/exposure.htm
271
Irwig, Les, 2006. Evaluating new screening tests for breast cancer. BMJ, 332, 678–679.
272
Гистерэктомия (hysterectomy) – хирургическое удаление матки. – Примеч. ред.
273
www.well-connected.com/rreports/doc06full.html
274
www.well-connected.con'i/rreports/doc06full.html
275
Keyomarsi, K., Tucker, S. L., Buchholz, T. A., Callister, M., Ding, Y., Hortobagyi, G. N., Bedrosian, I. Knickerbocker, C., Toyofuku, W., Lowe, M., Herliczek, T. W., and Bacus, S. S., 2002. Cyclin E and Survival in Patients with Breast Cancer. N. Engl. J. Med., 347, 1566–1575.
276
Yancik, R. and Ries, L. A., 1994. Cancer in older persons. Magnitude of the problem – how do we apply what we know? Cancer, 74 (7 Suppl), 1995–2003.
277
Silliman, R. A. and Baeke, P., 1998. Breast cancer in the older woman. In: Balducci, L., Ersher, W. B. and Lyman, G. H., Comprehensive geriatric oncology. Amsterdam: Harwood.
278
Welch, H. G., Albertson, F. C., Nease, R. F., Bubolz, T. A. and Wasson, J. H., 1996. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med, 124, 577–584.
279
Holmes, F. F., 1994. Clinical course of cancer in the elderly. Cancer Control, 1, 108–114.
280
Nixon, A. J., Neuberg, D., Hayes, D. F., Gelman, R., Connolly, J. L., Schnitt, S. and others, 1994. Relationship of patient age to pathological features of the tumor and prognosis for patients with stage I or II breast cancer. J. Clin. Oncol., 12, 888–894.
281
Balducci, Lodovico and Phillips, D. Melissa. 1998. Breast cancer in older women. American Family Physician. October 1, 1998. www.aafp.org/afp/981001ap/balducci.html
282
www.well-connected.com/rreports/doc06full.html
283
Medical Report: Prostate Cancer. ICON, 2002, 1 (5), 8–10.
284
Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.
285
http://www.nccn.org/paticnt_gls/_english/_prostate/
286
http://www.nccn.org/patient_gls/_english/_prostate/
287
Hart, D. and Wall, 2004. UK population dose from medical examinations. European Journal of Radiology, 50 (3), 285–291, Brenner, D. I. and others, 2001. CT scanning of children has been calculated 10 increase their lifetime risk of cancer. American Journal of Roentology, 176, 289–296.
288
http://www.nccn.org/patient_gls/_english/_prostate/
289
http://www.cancer.org
290
Spurgeon, David, 2003. Advanced scanning techniques help doctors stage prostate cancer. BMJ, 326, 1418.
291
New England Journal of Medicine, 2003, 348, 2491–2499.
292
http://www.nccn.org/patient_gls/_english/_prostate/
293
Fisher, B. and others, 2002. Twenty year follow-up of a randomised trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine, 347 (16), 1233–1241.
294
Fisher, B., Bryant, J., Dignam, J. J., Wickerham, D. L., Mamounas, E. F., Fisher, E. R., Margolese, KG., Nesbitt, L., Paik, S., Pisansky, T. M., Wolmark, N., 2002. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J. Clin. Oncol., 20 (20), 4141–4149; www.ncbi.nlm.nih.gov;80
295
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J. H. and Wolmark, N., 2002. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med., 347 (16), 1233–1241; www.ncbi.nlm.nih.gov;80
296
Gottlieb, Scott. Lumpectomy is as effective as mastectomy for breast cancer. BMJ, 325, 921.
297
www.nlm.nih.gov/medlineplus/ency/article/002919.htm
298
www.nlm.nih.gov/medlineplus/ency/article/002919.htm
299
www.cancer.org/docroot/cri/content/cri_2_6x_breast_reconstruction_after_mastectomy_5.asp
300
Bartelinkh and others, 2001. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. New England J. Med., 345 (19), 1378–1387.
301
http://cis.nci.nih.gov/fact/7_16.htm
302
Morrow, Monica and Gradishar, William, 2002. Recent Development: Breast Cancer. BMJ, 324, 410–414.
303
Coombes, R. C. and others, 2006. American Society of Clinical Oncology, Annual Meeting, Atlanta Georgia, June 2006.
304
Gralow, Julie R., 2002. Bisphosphonates as adjuvant treatment for breast cancer. BMJ, 325, 1051–1052.
305
www.gene.com/gene/products/information/oncology/herceptin; www.herceptin.com/herceptin/physician/pi.htm
306
www.herceptin.com/herceptin/physician/pi.htm
307
Anon, 2006. Patient is to appeal High Court ruling on breast cancer drug. BMJ, 332–443.
308
Barrett, A. and others, 2006. How much will herceptin really cost? BMJ, 333, 1118–1120.
309
Daily Mail, Monday, 9 October, 2006.
310
www.ahrq.gov/news/press/pr2002/brchempr.htm
311
www.ahrq.gov/news/press/pr2002/brchempr.htm
312
http://cis.nci.nih.gov/fact/7_16.htm
313
Gottlieb, Scott, 2002. Tamoxifen may increase risk of uterine sarcoma, BMJ, 325, 7.
314
http://cis.nci.nih.gov/fact/7_16.htm
315
Mayor, Susan, 2002. Anastrozole shows promise for early breast cancer. BMJ, 324, 1539
316
www.gene.com/gene/products/information/oncology/herceptin; www.herceptin.com/herceptin/physician/pi.htm
317
http://cis.nci.nih.gov/fact/7_45.htm
318
New Scientist, 20 January, 2007.
319
Editorial, New Scientist, 31 March, 2007.
320
Josefson, Deborah, 2002. Doctors warned to be wary of new drugs. BMJ, 324, 1113.
321
Garattini, Silvio and Bertele, Vittorio, 2002. Efficacy, safety, and cost of new anticancer drugs. BMJ, 325, 269–271.
322
www.cancer.gov
323
Modified after: Chemotherapy and You: A Guide to Self-Help During Cancer Treatment. Information about what to expect during chemotherapy and what patients can do to take care of themselves during and after treatment NIH Publication #99–1136: www.cancer.gov/cancerinfo/chemorherapy-and-you
324
Smith, I. and Chue, S., 2006. Medical treatment of early breast cancer. BMJ, 332, 162–181.
325
Allison, R. and others, 2006. Photodiagnosis and photodynamic therapy, 3, 139–146.
326
Fritsch, C. and Ruzika, T., 2003. Fluorescence diagnosis and photodynamic therapy of skin diseases atlas and handbook. Vien: Springer-Verlag.
327
Абляция (лат. ablatio – отнятие) – специфическое хирургическое вмешательство; абляция подразумевает под собой выжигание или выпаривание дисфункциональной или патологически измененной ткани с использованием лазера, радиочастотного аппарата, тока или химии; также данная операция может проводиться классическим хирургическим вмешательством. – Примеч. ред.
328
Coulter; Angela, 2003. Killing the goose that laid the golden egg. BMJ, 326, 1280.
329
Coulter, Angela, 2003. Killing the goose that laid the golden egg. BMJ, 326, 1280.
330
Ernst, E., 2003. Herbal medicines put into context. BMJ, 327, 881–882.
331
Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.
332
Dyer, Owen, 2003. Aspirin could be used to prevent cancer. BMJ, 326, 565.
333
Flower, Rod, 2003. What are all the things that aspirin does? BMJ, 327, 572–573.
334
UK limits use of aspirin by under 16s. BMJ, 2002, 324, 1294.
335
Astralagus. ICON, 2002, 1 (3), 23.
336
Bartram, T., 1998. Bartram's encyclopedia of herbal medicine. Robinson publishing.
337
Campbell, T. C. and Campbell, T. M., 2006. The China Study. Benbella Books.
338
Рейки – вид комплементарной медицины, в котором используется техника так называемого исцеления путем наложения рук. – Примеч. ред.
339
Greenwald, Peter, 2002. Cancer chemoprevention. BMJ, 324, 714–718.
340
Clarke, M.F. and Becker, M.W., 2006. Stem cells: the real culprits in cancer? Scientific American, July 2006, 53–59.
341
Study reveals how growth factors affect human stem cells. www.hhmi.org/news/melton.hmtl
342
Murray, R.K., Granner, D.K., Mayes, P.A. and Rodwell, V.W., 1990. Harper's Biochemistry. Appleton and Lange Norwalk, CT, p. 653.
343
Woolf, Neville, 1998. Pathology, Basic and Systemic. W.B. Saunders Publishing Co., Chapter 28, p. 274, Figure 28.
344
www.intouchlive.com/cancergenetics/onco.htm
345
Ludwig, T., Fisher, P., Ganesan, S. and Efstratiadis, 2001. Tumorigenesis in mice carrying a truncating BRCA1 mutation. Genes and Development, Vol. 15 (10), 1188–1193.
346
Xu, X., Wagner, K.U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A. and Deng, C.X. 1999. Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genetics, Vol. 22 (1), 37–43.
347
Paull, T.T, Cortez, D., Bowers, B., Elledge, S.J. and Gellert, M., 2001. Direct DNA binding by BRCA1. Proceedings of the National Academy of Sciences of the USA , Vol. 98 (11), 6086–6091.
348
Jensen, R.A., Thompson, M.E., Jetton, T.L., Szabo, C.I., van der Meer, R., Helou, B., Tronick, S., King, M.C., Page, D.L. and Holt, J.T., 1996. BRCA1 is secreted and exhibits properties of a granin. Nature Genetics, 12, 303–308; www.mc.vanderbilt.edu/cancer/research/roster/jensen.html
349
Struewing, J.P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M.M., Collins, F.S. and Brody, L.C., 1995. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi-Jewish individuals. Nature Genetics, 11, 198–200; http://rex.nci.nih.gov/massmedia/back-grounders/ashkenazi.html
350
Roa, B.B., Boyd, A.A., Volcik, K. and Richards, C.S., 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genetics, 14, 185–187; Oddoux, C., Struewing, J.P., Clayton, C.M., Neuhausen, S., Vrody, L.C., Kaback, M., Haas, B., Norton, L., Borgen, P. Jhanwar, S., Golgar, D., Ostrer, H. and Offit, K., 1996. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1 %. Nature Genetics, 14, 188–190; http://rex.nci.nih.gov/massmedia/backgrounders/ashkenazi.html
351
www.mercola.com/2002/apr/27/sv40.htm
352
Hursting, S.D., Slaga,T.J., Fischer, S.M., DiGiovanni, J. and Phtans, J. M., 1999. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. Journal of the National Cancer Institute, 35, 2031–2038.
353
Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine. Churchill Livingston.
354
Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine. Churchill Livingston.
355
Stewart, H.J., 1989. Clinical experience in the use of antioestrogen tamoxifen in the treatment of breast cancer. Proceedings of the Royal Society of Edinburgh , 95B, 231–237.
356
Miller, W. R., 1997. Aromatase inhibitors and breast cancer. Cancer Treatment Reviews, 23, 113–131.
357
Dao, T.L., Sinha, D.K., Nemato, T. and Patel, J., 1982. Effects of estrogens and progesterone on cellular replication of human breast tumours. Cancer Research, 42, 359–362.
358
Conte, P.P., Fraschini, G. and Dewinko, B., 1985. Estrogen induced expansion of the growth fraction in receptor negative human breast cancer. Journal of Steroid Biochemistry, 23, 1169–1172.
359
Miller, W.R. and Langdon, S.P., 1997. Hormonal, growth factor and cytokine control of breast cancer. In: Biology of Female Cancers, pp. 43–60. Langdon, S,P., Miller, W.R. and Berchuck, A. (editors). New York: CRC Press.
360
Miller, W.R., 1991. Oestrogens and breast cancer: biological considerations, British Medical Bulletin, 47, 470–483.
361
Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl Cancer Inst, 92, 1472–1489.
362
Rose, Steven, with Mileusnic, Radmila, 1999. The Chemistry of Life. Fourth (revised) edition. Penguin Books.
363
Voet, Donald and Voet, Judith, 1995. Biochemistry. Second edition. John Wiley & Sons, Inc.
364
Jiang, Wen G., Matsumoto, Kunio and Nakamura, Toshikazu (editors), 2001, Growth Factors and their Receptors in Cancer Metastasis. Dordrecht: Kluwer Academic Publishers.
365
Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst., 92, 1472–1489.
366
Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst., 92, 1472–1489.
367
www.ucop.edu/srphome/bcrp/progressreport/abstracts/innov/3CB-0186.html
368
Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst., 92, 1472–1489.
369
www.preventcancer.com/pdf/InsulinGrowth266.html
370
www.dep.iarc.fr/globocan/database.pdf
371
Эту обновленную таблицу нельзя напрямую сравнивать с более ранней версией, приведенной выше, поскольку ВОЗ изменила группировку и методы стандартизации по возрасту. Информация из Гонконга включена в статистику Китая.
372
WHO International Agency for Research on Cancer (IARC), IARC Cancer Epidemiology Database. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. Ferlay, J., Bray, F., Piesci, P. and Parkin, D.M. (editors), www.dep.iarc.fr/globocan/database.pdf
373
American Cancer Society. Modelled data: cancer facts and figures, 2006.
374
www.cancerresearchuk.org
375
www.cancerresearchuk.org
376
www.cancerresearchuk.org
377
Pike M.C., Kolonel, L.N., Henderson, B.E., Wilkens, L.R., Hankin J.H., Feigelson, H.S., Wan, P.C., Stram, D.O. and Nomura, A.M., 2002. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev., 11 (9), 795–800.
378
www.hawaii.edu/crch/ProfileKolonel.htm
379
www.yoursurgery.com/ProcedureDetails.cfm?BR=3&Proc=36
380
American Cancer Society. Modelled data: cancer facts and figures, 2006.
381
Worldwide Cancer Mortality Statistics, ASR(w) for Annual Mortality per 100 000 by sex and age group. http://www.depd.iarc.fr/who/menu.htm
382
Yancik, R. and Ries, L.A., 1994. Cancer in older persons. Magnitude of the problem: how do we apply what we know? Cancer, 74 (7 Suppl), 1995–2003.
383
Silliman, R.A. and Baeke, P., 1998. Breast cancer in the older woman. In: Balducci, L., Ersher, W.B. and Lyman, G.H. Comprehensive geriatric oncology. Amsterdam: Harwood.
384
Welch, H.G., Albertson, P.O., Nease, R.F., Bubolz, T.A. and Wasson, J.H., 1996. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med, 124, 577–584.
385
Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.
386
Dobson, R., 2006. Breast cancer incidence rises in contaminated areas 10 years after explosion at Chernobyl reactor. BMJ, 332, 567.
387
Jakes, R.W. and others, 2002. Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiological Biomarkers Prev., 11, 608–613.
388
www.cancer.org; www.cancer.org/docroot/CRI/content/CRl_2_4_2X_What_are_the_risk_factors_for_breast_cancer_5.asp
389
Dobson, R., 2006. Diethylstilbestrol increase risk of breast cancer death. BMJ, 333, 64.
390
www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk_factors_for_male_breast_cancer_28.asp
391
www.dep.iarc.fr/globocan/database.pdf
392
WHO International Agency for Research on Cancer (IARC), IARC Cancer Epidemiology Database. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. Ferlay, J., Bray, F., Piesci, P. and Parkin, D.M. (editors). www.dep.iarc.fr/globocan/database.pdf
393
Campbell, T.C., and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. American Journal of Clinical Nutrition, 59, Suppl., 11 535-11 615.
394
Jakes, Rupert W., Duffy, Stephen W., Ng, Fook-Cheong, Gao, Fei, Ng, Eng-Hen, Seow, Adeline, Lee, Hin-Peng and Yu, Mimi C., 2002. Mammographic Parenchymal Patterns and Self-reported Soy Intake in Singapore Chinese Women. Cancer Epidemiology Biomarkers & Prevention, 11, 608–613.
395
Statistical Abstracts of the US, 1994 edition.
396
T. Colin Campbell, quoted in www.milksucks.com/osteo.html; Robbins, John, 1987, A Diet for a New America. Stillpoint Publishing; McDougall, John, 2000. The McDougall Program for Women; Plant, Jane and Tidey, Gill, 2003. Understanding, Preventing and Overcoming Osteoporosis. Virgin Books.
397
FAO (англ. Food and Agriculture Organization) – продовольственная и сельскохозяйственная организация ООН. – Примеч. ред.
398
IARC Cancer Epidemiology Database. GLOBOCAN 2000, Cancer incidence, mortality and prevalence worldwide. Ferlay, J., Bray, F., Piesci, P., and Parkin, D.M. (editors), www.dep.iarc.fr/globocan/database.pdf
399
Frassetto, L.A., Todd, K.M., Morris, R.C., Jr and Sebastian, A., 2000. Worldwide incidence of hip fracture in elderly women: relation to consumption of animal and vegetable foods. Journal of Gerontology: Medical Sciences, 55A. 10, M585-M592.
400
Jakes, Rupert W., Duffy, Stephen W., Ng, Fook-Cheong, Gao, Fei, Ng, Eng-Hen, Scow, Adeline, Lee, Hin-Peng and Yu, Mimi C., 2002. Mammographic Parenchymal Patterns and Self-reported Soy Intake in Singapore Chinese Women. Cancer Epidemiology Biomarkers & Prevention, 11, 608–613.
401
Pringle, H., 1998. Neolithic agriculture: reading the signs of ancient animal domestication. Science. 282, 1448.
402
Thomas M and others, 2007, Proc. Nat. Acad. Sci.
403
Latham, M.C., 1997. Human nutrition in the developing world, Rome, 1997. FAO Food and Nutrition Series № 29, Cornell University, Ithaca, N Y.
404
Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
405
AbuGhazaleh, A.A. and others, 2004. CLA increases in milk when cows fed fish meal and extruded soybeans for an extended period of time. Journal of Dairy Science, 87 (6), 1758–1766.
406
Petit, H.V., 2002. Digestion, milk production, milk composition, and blood composition of dairy cows fed whole fl ax seed. Journal of Dairy Science, 85 (6), 1482–1490.
407
Wahle, K.W. and others, 2004. CLAs: are they beneficial or detrimental to health? Progress in Lipid Research, 43 (6), 553–587.
408
Willett, W.C, and Stampfer, M.J., 2007. Rebuilding the food pyramid. Scientific American, Special edition on diet and health, February 2007, 12–21.
409
The Royal Society, 2000. Endocrine-disrupting chemicals. Document 06/00. The Royal Society.
410
Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
411
Qin, L.Q. and others, 2004. Estrogen: one of the risk factors in milk for prostate cancer. Medical Hypotheses, 62 (1), 133–142.
412
Hartman, S. and others, 1998. Natural occurrence of steroid hormones in food. Food Chemistry, 62, 7-20.
413
Buder, J., 2006. White lies. Vegetarian and Vegan Foundation.
414
Ganmaa, D. and Sato, A., 2005. Possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Medical Hypotheses, 65 (6), 1028–1037.
415
DEFRA, 2005. Agriculture in the UK, 2004. Norwich, UK: HMSO.
416
Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. Am. J. Clin. Nutr., 59, Suppl., 11 535-11 615.
417
Charatan, Fred, 2003. Book Review: Fat Land: How Americans Became the Fattest People in the World, by Greg Critser. BMJ, 326, 229.
418
Charatan, Fred, 2003. Book Review: Fat Land: How Americans Became the Fattest People in the World, by Greg Critser. BMJ, 326, 229.
419
Charatan, Fred, 2003. Book Review; Fat Land; How Americans Became the Fattest People in the World, by Greg Critser. BMJ, 326, 229.
420
Grosvenor, C.E. and others, 1992. Hormones and growth factors in milk. Endocrine Reviews, 14 (6), 710–728.
421
http://www.dhn.csiro.au/crctissue.html
422
http://www.13.waisays.com/cancer2.htm
423
le Huerou-Luron, I. and others, 1998. Source of dietary protein influences kinetics of plasma gut regulatory peptide concentration to feeding in preruminant calves. Comparative Biochemistry and Physiology: A – Molecular and Integrative Physiology, 119 (3), 817–824.
424
Koldovski, O. and others, 1995. Milk-borne hormones: possible tools of communication between mother and suckling. Physiological Research, 1995, 44 (6), 349–351, Koldovsky, O. and others, 1994. Hormonally active peptides in human milk. Acta Paediatrica Suppl., 402, 89–93; Lehy,T. and others, 1990. Promoting effect of bombesin on the cell proliferation in the rat endocrine pancreas during the early post natal period. Regulatory Peptides, 27 (1), 87–96; Pollack, P.F., 1989. Effects of enterally– and parenterally-administrated bombesin on intestinal luminaltryptic activity and protein in the suckling rat. Experienta, 45 (4), 385–388; Lazarus, L.H. and others, 1986. An immunoreactive peptide in milk contains bombesin-like bioactivity. Experienta, 42 (7), 822–823; Jahnke, G.D. and others, 1984. A bombesin immunoreactive peptide in milk. Proc. Natl. Acad. Sci. USA, 81 (2), 578–582.
425
Berseth, C.I. and others, 1990. Postpartum changes in pattern of gastrointestinal regulatory peptides in human milk. Am. J. Clin. Nutr., 51 (6), 985–990.
426
Burns, D.M. and others, 1999. Breast cancer cell-associated endopeptidase EC24.11 modulates proliferative response to bombesin, British Journal of Cancer, 79 (2), 214–220; Bold, R.J, and others, 1998. Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptor status. Anticancer Research, 18 (16A), 4051–4056; Miyazaki, M. and others, 1998. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-11 and RC-3095. European Journal of Cancer, 34 (5), 710–717; Nelson, J, and others, 1991. Bombesin stimulates proliferation of human breast cancer cells in culture. Br. J. Cancer, 63 (6), 933–936; Giacchetti, S. and others, 1990. Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells. Int J. Cancer, 46 (2), 293–298; Weber, C.J. and others, 1989. Gastrin-releasing peptide, calcitonin gene-related peptide, and calcitonin-like immuno-reactivity in human breast cystfluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines. Surgery, (6), 1134–1139 (disc. 1139–1140).
427
Markwalder, R. and others, 1999. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Research, 59 (5), 1152–1159; Festuccia, C. and others, 1998. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int. J. Cancer, 75 (3); 418–431: Krongrad, A. and others, 1997. Endopeptidase 24.11 activity in the human prostate cancer cell lines LNCaP and PPC-1. Urological Research, 25 (2), 113–116; Jungwirth, A. and others, 1997. LHRH antagonist Cetrolix (SB-75) and bombesin-antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate, 32 (3), 164–172; Larran, J. and others, 1996. In vitro characterization of bombesin and calcitonin on the proliferation of PC3, DK145 and LNCaP cancer prostatic cell lines. International Journal of Developmental Biology, 1996 (Suppl. 1), 275S–276S; Aprickian, A.G. and others, 1996. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostatic cancer cells. Journal of Molecular Endocrinology, 16 (3), 297–306; Bologna, M. and others, 1989. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer, 63 (9), 1714–1720; Wasilenko, W.J. and others, 1996. Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines. Int J. Cancer, 68 (2), 259–264.
428
Takeyama, M. and others, 1989. Enzyme immunoassae of gastrin-releasing, peptide (GRP)-like immunoreactivity in milk. Int. J. Pept. Protein Res., 34 (1), 70–74.
429
Ducroc, R. and others, 1995. Immunoreactive substance P and calcitonin-gene-related peptide (CGRP) in rat milk and in human milk and infant formula's. Am. J. Clin. Nutr., 62 (3), 554–558.
430
Lembeck, F. and others, 1979. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Arch. Pharmacol., 310 (2), 175–183.
431
Khare, V. K. and others, 1998. The neuropeptide/mast cell secretagogue substance F is expressed in cutaneous melanocyticlesions. Journal of Cutaneous Pathology, 25 (1), 2-10.
432
Ducroc, R. and others, 1995. Immunoreactive substance P and calcitonin-gene-related peptide (CGRP) in rat milk and in human milk and infant formula's. Am. J. Clin. Nutr., 62 (3), 554–558.
433
Faulkner, A., 1998. Insulin-like growth factor 1 concentrations in milk and plasma after growth hormone treatment. Biochemical Society Transactions, 26 (4), 386; Silanikove, N. and others, 1998. Metabolic and productive response of dairy cows to increased ion supplementation at early lactation in warm weather. Journal of Dairy Research, 65 (4), 529–543; Ginjala, V. and others, 1998. Determination of transforming growth factor-beta 1 (TGF-beta 1) and insulin-like growth factor-1 (IGF-1) in bovine colostreum samples. Journal of Immunoassay, 19 (2–3), 195–207; Schober, D.A. and others, 1990. Perinatal expression of type 1 IGF receptors in porcine small intestine. Endocrinology, 126 (2), 1125–1132.
434
Rao, R.K. and others, 1998. Luminal stability of insulin-like growth factor-1 and -2 in developing rat gastrointestinal tract. Journal of Pediatric Gastroenterology and Nutrition, 26 (2), 179–185.
435
Parisot, J.P. and others, 1999. Altered expression of the insulinlike growth factor-1 receptor in a tamoxifen-resistant human breast cancer cell line. Br. J. Cancer, 79 (5–6), 693–700; Sciacca, L. and others, 1999. Insulin receptor activation by insulin-like growth factor– 2 in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene, 18 (15), 2471–2479; Grothey, A. and others, 1999. The role of insuline-like growth factor and its receptor in cell growth transformation, apoptosis, and chemoresistance In solid tumors. Journal of Cancer Research and Clinical Oncology, 125 (3–4), 166–173; Perks, C. M. and others, 1999. Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor-1 (IGF-1) in human breast cancer cell lines. Br. J. Cancer, 79 (5–6), 701–706; de Cupis, A. and others, 1998. Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line; comparison between early and late cultures. In Vitro Cellular and Developmental Biology – Animal, 34 (10), 836–843; Kobari, M. and others, 1998. The inhibitory effect of an epidermal growth factor receptor specific tyrokinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF-1. International Journal of Pancreatology, 24 (2), 85–95; Gooch, J.L. and others, 1998. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res., 58 (18), 4199–4205; Choki, I. and others, 1998. Osteobiast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells. Anticancer Res., 18 (16A), 4213–4224; Jackson, J.G. and others, 1998, Insulin receptor substrate-1 is the predominant signalling molecule activated by insulin-like growth factor-1, insulin, and interleukin– 4 in estrogen receptor-positive human breast cancer cells. Journal of Biological Chemistry, 273 (16), 9994-10 003; Westley, B.R. and others, 1998. Interactions between the oestrogen and IGF signalling pathways in the control of breast epithelial cell proliferation. Biochemical Society Symposium, 63, 35–44; Surmacz, E. and others, 1995. Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation. Clinical Cancer Research, 1 (11), 1429–1436.
436
Untersasser, G. and others, 1999. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors. Experimental Gerontology, 34 (2), 275–287; Xu, Z.D., 1999. Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-2 ribonucleic acid in vitro and in prostate cancer cells. Endocrinology, 140 (5), 2134–2144; Marelli, M.M. and others, 1999. Luteinizing hormone-releasing hormone agonists interfere with the antagonic activity of the insulin-like growth factor system in androgen-dependent prostate cancer cells. Endocrinology, 140 (1), 329–334; Larnharzi, N. and others, 1998. Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DY-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor– 2 in tumors. Proc. Natl. Acad. Sci. USA, 95 (15), 8864–8868; Wang, Y.Z. and others, 1998. Sex hormone-induced prostatic carcinogenesis in the noble rat; the role of insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) in the development of cancer. Prostate, 35 (3), 165–177.
437
He, Y., 1999. Comment on the Association between InsulinLike Growth Factor-1 (IGF-I) and Bone Mineral Density: Further Evidence Linking IGF-I to Breast Cancer Risk. Journal of Cellular Endocrinology and Metabolism, 84, 1760.
438
Perks, C. M. and Holly, J.M.P., 2000, Insulin-Like Growth Factor Binding Proteins (IGFBPs) in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia, 5, 75–84.
439
Murphy, M.S. and others, 1998. Growth factors and the gastrointestinal tract. Nutrition, 14 (10), 771–774; Buts, J.F., 1998, Bioactive factors in milk. (in French.) Archives de Pediatrie, 5 (3), 298–306.
440
Shen, W.H. and others, 1998. Stability and distribution of orally administered epidermal growth factor in neonatal pigs. Life Sciences, 63 (10), 809–820; Rao, R.K. and others, 1998. Bovine milk inhibits proteolytic degradation of epidermal growth factor in human gastric and duodenal lumen. Peptides, 19 (3), 495–504; McCuskey, R.S. and others, 1997. Effect of milkborne epidermal growth factor on the hepatic microcirculation and Kupfer cell function in suckling rats. Biology of the Neonate, 7 (3), 202–206; Oguchi, S. and others, 1997. Growth factors in breast milk and their effect on gastrointestinal development. Chang Hua Min Kuo Hsiao Ehr Ko I Hsuek Tsa Chih, 38 (5), 332–337.
441
Salomon, D.S. and others, 1999. Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia. Bioessays, 21 (1), 61–70; Chou, Y.C. and others, 1999. Induction of mammary carcinomas by N-methyl-N-nitrosurea in ovariectomized rats treated with epidermal growth factor. Carcinogenesis, 20 (4), 677–684; Kurtz, A. and others, 1998. Local control of mammary gland differentiation: mammary-derived growth inhibitor and pleiotrophin. Biochemical Society Symposium, 63, 51–69; Taylor, M.R. and others, 1997. Lactadherin (formerly BA46); a membrane-associated gycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion. DNA and Cell Biology, 16 (7), 861–869.
442
Zhau, H.J. and others, 1996. Androgen-depressed phenotype in human prostate cancer. Proc. Natl. Acad. Sci. U.S.A., 93 (26), 15 152-15 157.
443
Thornburg, W. and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246, G80-G85.
444
www.prostatepointers.org/cmyers/pf0696.html
445
Gaull, G.E. and others, 1985. Significance of growth modulators in human milk. Pediatrics, 75 (2), 142–145.
446
Delgrange, E. and others, 1997. Sex related differences in the growth of prolacrinomas: a clinical and proliferation marker study. Journal of Clinical Endocrinology and Metabolism. 82 (7), 2102–2107.
447
Vonderhaar, B.K., 1998, Prolactin: The forgotten hormone of human breast cancer. Pharmacology and Therapeutics, 79 (2), 169–178; Das, R. and others; 1996. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells. Oncogene, 13 (6), 1139–1145; Mershon, J, and others, 1995. Prolactin is a local growth factor in rat mammary tumors. Endocrinology, 136 (8), 3619–3623; Ginsberg, E. and others, 1995. Prolactin secretion by human breast cancer cells. Cancer Res, 55 (12), 2591–2595; Fuh, G. and others, 1995. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol Chem, 270 (22), 13 133-13 137.
448
Leav, I. and others, 1999. Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions. American Journal of Pathology, 154 (3), 863–870; Horti, J. and others, 1998. A phase 2 study of bromocriptine in patients with androgen-independent prostate cancer. Oncology Reports, 5 (4), 893–896; Franklin, R.B. and others, 1997. Prolactin regulation of mitochondrial aspartate aminotransferase and proteinkinase C Molecular and Cellular Endocrinology, 127 (1), 19–25; Janssen, T. and others, 1996. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate. Cancer, 77 (1), 144–149; Janssen, T. and others, 1995. Organ culture of human tissue as study model of hormonal and pharmacological regulation of benign prostatic hyperplasia and of prostatic cancer, (frans) Acta Urol Belg, 63 (1), 7-14; Oliver, R.T. and others, 1995. New directions with hormone therapy in prostate cancer: possible benefit from blocking prolactin and use of hormone treatment intermittently in combination with immunotherapy. Eur. J. Cancer, 31A (6), 859–860; Rana, A. and others, 1995. A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate. Eur. J. Cancer, 31A (6), 871–875.
449
Hinuma, S. and others, 1998. A prolactin-releasing peptide in the brain. Nature, 393 (6682), 272–276.
450
Smith, S.S. and others, 1986. Presence of luteinising hormonereleasing hormone (LHRH) in milk. Endocrinol Exp., 2 °C2-3), 147–153; Koldovsky, O., 1989. Search for the role of milk borne biologically active peptides for the suckling. J.Nutr., 119 (II), 1543–1551; Nair, R.M. and others, 1987. Studies on LHRH and physiological fluid amino acids in human colostreum and milk. Endocrinolologia Experimentalis, 21 (1), 23–30.
451
White, M.E. and others, 1986. Milk progesterone concentrations following simultaneous administration of buserelin and cloprostenol in cattle with normal corporal lutea. Canadian Journal of Veterinary Research, 50 (2), 285–286; Dinsmore, R.P. and others, 1989. Effect of gonadotropin-releasing hormone on clinical response and fertility in cows with cystyic ovaries, as related to milk progesterone concentration and days after partarition. Journal of the American Veterinary Medical Association, 195 (3), 327–330.
452
Berseth, C.I. and others, 1990. Postpartum changes in pattern of gastrointestinal regulatory peptides in human milk. Am. J. Clin. Nutr., 51 (6), 985–990.
453
Berseth, C.I. and others, 1990. Postpartum changes in pattern of gastrointestinal regulatory peptides inhuman milk. Am. J. Clin. Nutr., 51 (6), 985–990.
454
Flood, J.F. and others, 1991. Increased food intake by neuropeptide Y is due to an increased motivation to eat. Peptides, 12 (6), 1329–1332.
455
Amarant, T. and others, 1982. Luteinising hormone-releasing hormone and thyrotropin-releasing hormone in human and bovine milk. European Journal of Biochemistry, 127 (3), 647–650; Baram, T and others, 1977. Gonadotropin-releasing hormone in milk. Science, 198 (4314), 300–302.
456
Koike, K. and others, 1997. The pituitary folliculo-stellate cell line TtT/GF augments basal and TRH-inducedprolactin secretion by GH3 cells. Life Sci, 61 (25), 2491–2497; Tyson, J.E. and others, 1975. The influence of prolactine secretion on human lactation. J. Clin. Endocrinol Metab, 40 (5), 764–773.
457
Grochowska, R. and others, 1999. Stimulated growth hormone (GH) release in Friesian cattle with respect to GH genotypes. Reproduction Nutrition Development, 39 (2), 171–180; Bourne, R.A. and others, 1977. Serum growth hormone concentrations after growth hormone or thyroid-releasing hormone in cows. Journal of Dairy Science, 60 (10), 1629–1635.
458
Chomczinsky, P. and others, 1993. Stimulatory effect of thyroid hormone on growth hormone gene expression in a human pituitary cell line. J. Clin. Endocrinol Metab, 77 (1), 281–285; Reynolds, A.M., 1991. The effects of chronic exposure to supra physiological concentrations of 3,5,3-triiodo-L-thyronine (T3) on cultured GC cells. Journal of Cellular. Physiology, 149 (3), 544–547.
459
Tenore, A. and others, 1980. Thyroidal response to peroral TSH in suckling and weaned rats. American Journal of Physiology, 238 (5), E428-430.
460
Slebodzinski, A.B. and others, 1998. Triiodothyronine (T3), insulin and characteristics of 5'-monodiodinase (5'-MD) in mare's milk from partarition to 21 days post-partum. Reproduction Nutrition Development, 38 (3), 235–244.
461
Fujimoto, N. and others, 1997. Upregulation of the estrogen receptor by triiodothyronine in rat pituitary cell lines. Journal of Steroid Biochemistry and Molecular Biology, 61 (1–2), 79–85.
462
Koldovsky, O., 1989. Search for the role of milk borne biologically active peptides for the suckling. J. Nutr., 119 (11), 1543–1551; Buts, J.P., 1998. Bioactive factors in milk. (in French.) Arch Pediatr, 5 (3), 298–306.
463
Faulkner, A., 1998. Insulin-like growth factor concentrations in milk and plasma after growth hormone treatment. Biochemical Society Transactions, 26 (4), S386; Baldini, E. and others, 1994. In vivo cytokinetic effects of recombinant human growth hormone (rhGH) in patients with advanced breast carcinoma. Journal of Biological Regulators and Homeostatic Agents, 8 (4), 113–116; Scheven, B.A. and others, 1991. Effects of recombinant human insulin-like growth factor-1 and -2 (IGF) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regulation, 1 (4), 160–167; Hodate, K. and others, 1990, Plasma growth hormone, insuline-like growth factor-l, and milk production response to exogenous human growth hormone-releasing factor analogs in dairy cows. Endocrinologia Japonica, 37 (2), 261–273.
464
Koldovsky, O., 1989. Search for the role of milk borne biologically active peptides for the suckling. J. Nutr., 119 (11), 1543–1551; Buts, J.P., 1998. Bioactive factors in milk. (in French.) Arch Pediatr, 5 (3), 298–306.
465
Westrom, B.R. and others, 1987. Levels of immunoreactive insulin, neurotensin, and bombesin in porcine colostreum and milk. J. Pediatr. Gastroenterol. Nutr., 6 (3), 460–465; Ehman, R. and others, 1985. Bombesin, neurotensin and pro-gamma-melanotropin in immunoreactants in human milk. Regulatory Peptides, 10 (2–3), 99-105.
466
Shutt, D.A. and others, 1985. Comparison of total and free cortisol in bovine serum and milk colostreum. J. Dairy Set, 68 (7), 1832–1834.
467
Vaarala, O. and others, 1998. Cow milk feeding induces antibodies to insulin in children – a link: between cow milk and insulin-dependent diabetes mellitus? Scandinavian Journal of Immunology 47 (2), 131–135; Slebodzinsky, A.B. and others, 1998. Triiodothyronine (T3), insulin and characteristics of 5'-monodiodinase (5'-MD) in mare's milk from partarition to 21 days post-partum. Reprod Nutr Dev, 38 (3), 235–244; Westrom, B.R. and others, 1987. Levels of immunoreactive insulin, neurotensin, and bombesin in porcine colostreum and milk. J. Pediatr Gastroenterol Nutr., 6 (3), 460–465.
468
Ferrando, T. and others, 1990. Beta-endorphin-like and alpha-MSH-like immunoreactivities in human milk. Life Sci, 47 (7), 633–635.
469
http://www.13.waisays.com/cancer2.htm; Newcomb, P.A. and Egan, K.M., 2006. Dairy food and ovarian cancer risk. The Lancet, March 2006, 797–799; Stang, A. and others, 2006. Adolescent milk fat and galactose consumption and testicular germ cell cancer. Cancer Epidemiology and Biomarkers Prevention, 15, 2189–2195.
470
Maruuchi, T. and others, 1998. Effects of gonadotropin-releasing hormone agonist on rat ovarian adenocarcinoma cell lines in vitro and in vivo. Japanese Journal of Cancer Research, 89 (9), 977–983; Kuroda, H. and others, 1998. Human chorionic gonadotrophin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of up-regulation of IGF-1 by hCG. Int J. Cancer, 76 (4), 571–578; Kurbacher, C.M. and others, 1995. Influence of luteinising hormone on cell growth and CA 125 secretion of primary epithelial ovarian carcinomas in vitro. Tumour Biology, 16 (6), 374–384; Manetta, A. and others, 1995. Inhibition of growth of human ovarian cancer in nude mice by luteinising hormone-releasing hormone antagonist Cetrorelix (SB-75). Fertility and Sterility, 63 (2), 282–287.
471
Reiter, E. and others, 1999. Effects of pituitary hormones on the prostate. Prostate, 38 (2), 159–165; Lamharzi, N. and others, 1998. Luteinising hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF– 2 in tumors. Regulatory Peptides, 77 (113), 185–192; Jungwirth, A. and others, 1997. Luteinising hormone-releasing hormone (LH-RH) antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-2 inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate, 32 (3), 164–172; Maezawa, H. and others, 1997. Potentiating effect of buserelin acetate, an LHRH agonist on the proliferation of ventral prostatic epithelial cells in testosterone-treated castrated rats. Int J. Urol, 4 (4), 411–416; Using, A.W. and others, 1993. Serological precursors of cancer serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev, 2 (1), 27–32; Garde, S. and others, 1993. Effect of prostatic inhibiting peptide on prostate cancer cell growth in vitro and in vivo. Prostate, 7 (2), 183–194.
472
Bosland, M.C., 1996. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Progress in Clinical and Biological Research, 394, 309–352.
473
Chapman, S. and others, 1992. Changes in adult cigarette consumption per head in 128 countries, 1986–1990. Tobacco Control, 1, 281–284.
474
http://www.who.int
475
Chapman, S. and others, 1992. Changes in adult cigarette consumption per head in 128 countries, 1986–1990. Tobacco Control, 1. 281–284.
476
http://www.who.int
477
http://www.13.waisays.com/cancer2.htm
478
Underwood, L.E., D'Ercole, J.A. and Van Wyk, J.J., 1980. Somatomedin-C and the assessment of growth. Ped. Clin. N Amer, 27, 4, 771–782, and Perdue, J.F. 1984. Chemistry, structure and function of insulin-like growth factors and their receptors: a review. Can J. Biochem Cell Bio, 62, 1237–1245.
479
http://www.com/healthnews/milk.html
480
Pollack, Michael, 2003. Cancer, aging and IGF physiology. Meeting of the Royal Society of Medicine in London in October 2003, entitled «Biology of IGF-I: its interaction with insulin in health and malignant states».
481
Lonning, Per Eystein, 2003. IGF-I and breast cancer. Meeting of the Royal Society of Medicine in London in October 2003, entitled «Biology of IGF-I: its interaction with insulin in health and malignant states».
482
Yee, Doug, 2003. Targeting the IGF system for anti-tumour therapy. Meeting of the Royal Society of Medicine in London in October 2003, entitled «Biology of IGF-I: its interaction with insulin in health and malignant states».
483
Pollack, Michael, 2003. Cancer, aging and IGF physiology. Meeting of the Royal Society of Medicine in London in October 2003, entitled «Biology of IGF-I; its interaction with insulin in health and malignant states».
484
Holly, Jeff, 1998. Insulin-like growth factor-1 and new opportunities for cancer prevention. Lancet, 351, 9113, 9 May, 1373–1375.
485
Chan, J.M., Stampfer, M.J., Giovannucci, E. and others, 1998. Plasma insulin-like growth factor-I and prostate cancer risk; a prospective study. Science, 279, 563–566; Harman, S.M., Metter, E.J., Blackmail, M.R., Landis, P.K. and Carter, H.B., 2000. Serum levels of insulin-type growth factor 1 (IGF-I), IGF II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J. Clin. Endocrinol Metab., 85, 4258–4265; Stattin, P. and nine others, 2000. Plasma insulin-like growth factor-I insulin-like growth-binding proteins, and prostate cancer risk: a prospective study. J. Natl. Cancer Inst., 92, 1910–1917; Chokkalingam, A.P, and 12 others, 2001. Insulinlike growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev., 10, 421–427; Chan, J.M., Stampfer, M.J., Ma, J. and others, 2002. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J. Natl Cancer Inst, 94, 1099–1106; Mantzoros, C.S., Tzonou, A., Signorello, L.B. and others, 1997. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. British Journal of Cancer, 76, 1115–1118; Wolk, A., Mantzoros, C.S., Andersson, S.O. and others, 1998. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J. Natl Cancer Inst, 90, 911–915; Holly, J.M.P., Gunnell, D.J. and Davey Smith., G, 1999. Growth hormone, IGF-1 and cancer. Less intervention. Less intervention to avoid cancer? More intervention to prevent cancer. J. Endocrinol, 162, 321–330.
486
Yu, H. and others, 1999. Plasma levels of IGF-I and lung cancer risk, Journal of the National Cancer Institute, 91, 151–156.
487
Ma, J. and others, 2001. Milk intake, circulating levels of IGF-1 and risk of colorectal cancer in men. Journal of the National Cancer Institute, 93 (17), 1330–1336.
488
LeRoith, D. and others, 1995. The role of the IGF-I receptor in cancer. Annals of the New York Academy of Sciences, 766, 402–408; Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
489
Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.
490
Bradford Hill, A., 1965. The environment and disease; association or causation? Proceedings of the Royal Society of Medicine, 58, 295–300.
491
Holly, J.M.P., Gunnell, D.J. and Davey Smith, G., 1999. Growth hormone, IGF-I and cancer. Less intervention. Less intervention to avoid cancer? More intervention to prevent cancer. J. Endocrinol, 162, 321–330.
492
Bobbins, John, 1987. A Diet for a New America, Stillpoint Publishing.
493
www.dhn.csiro-au/crctissue.html
494
Xian, C., 1995. Degradation of IGF-I in the Adult Rat Gastrointestinal Tract is limited by a Specific Antiserum of the Dietary Protein Casein. Journal of Endocrinology, 146, 2, 1 August, 215; Thornburg, W. and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246, G80-G85.
495
The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating to Public Health – Outcome of discussions. http://europa.eu.int/comm/dg24/health/sc/scv/outl9_en.html
496
Allen, N.K, and others, 2000, Hormones and Diet; Low Insulin-like Growth Factor-1 but Normal Bioavailable Androgens in Vegan Men. Brit. J. Canc., 83 (1), 95–97.
497
Steinman, G., 2006. Can the chance of having twins be modified by diet? The Lancet, 367 (9521), 1461–1462.
498
Norat and others, 2007. Diet, serum IGF-1 and IGF-BP3 in European women. European Journal of Clinical Nutrition, 61, 91–98.
499
The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating to Public Health – Outcome of discussions. http://europa.eu.int/comm/dg24/health/sc/scv/out19_en.html
500
Heaney, R.P. and others, 1999. Dietary changes favourably affect bone remodelling in older adults, Journal of the American Dietetic Association, 99 (10), 1228–1233.
501
Gunnell, D.L. and 10 others, 2003. Are diet – prostate-cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. British Journal of Cancer, 88, 1682–1686.
502
World Cancer Research Fund, 1997. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: American Institute of Cancer Research.
503
Allen, N.E., Appleby, P.N., Davey, G. K. and Key, T.J., 2000. Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br. J. Cancer. 83, 95–97.
504
Yaker, S. and others, 2005. The role of the growth hormone/ IGF axis in tumour growth and progression: lessons from animal models. Cytokine and Growth Factor Reviews, 16 (4–5), 407–420; Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
505
Mannisto, S. and others, 1999. Diet and the risk of breast cancer in a case control study: does the threat of disease have an influence on recall bias? Journal of Clinical Epidemiology, 52 (5), 429–439; Outwater, J.L. and others, 1997. Dairy products and breast cancer: the IGF-1, estrogen and bGH hypothesis. Medical Hypotheses, 48 (6), 453–461; Gaard, M. and others, 1995. Dietary fat and the risk of breast cancer: a prospective study of 25 892 Norwegian women. Int J. Cancer, 63 (1), 13–17; Decarli, A. and others, 1986, Environmental factors and cancer mortality in Italy: correlational exercise. Oncology, 43 (2), 116–126; Rose, D.P. and others, 1986. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer, 58 (11), 2363–2371; Shimada, A. and others, Ecological approach to the eating habits and the cancer mortality of Brazilian people. (in het Japans) Can No Rinsho, 32 (6), 631–640; La Vecchia, C. and others, 1986, Age at first birth, dietary practises and breast cancer mortality in various Italian regions. Oncology, 43 (1), 1–6; Talamini, R. and others, 1984. Social factors, diet and breast cancer in a northern Italian population. Br. J. Cancer. 49 (6), 723–729.
506
Rose, D. P. and others, 1986. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer, 58 (11), 2363–2371.
507
Schuurman, A.G. and others, 1999, Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study, Br. J. Cancer, 80 (7), 1107–1113; Giovannucci, E., 1999. Nutritional factors in human cancers. Advances in Experimental Medicine and Biology, 472, 29–42; Giovanucci, E., 1998. Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes and Control, 9 (6), 567–582; Willet, W.C., 1997. Nutrition and Cancer. Salud Publica de Mexico, 39 (4), 298–309; De Stefani, E. and others, 1995, Tobacco, alcohol, diet and risk of prostate cancer. Tumori, 81 (5), 315–320; Le Marchand, L. and others, 1994. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology, 5 (3), 276–282; Talamini, R. and others, 1992. Diet and prostate cancer: a case control study in northern Italy. Nutrition and Cancer, 18 (3), 277–286; La Vecchia, C. and others, 1991. Dairy products and the risk of prostatic cancer. Oncology, 48 (5), 406–410; Mettlin, C. and others, 1989. Beta-carotene and animal fats and their relationship to prostate cancer risk. A case control study. Cancer, 64 (3), 605–612; Snowdon, D.A., 1988. Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-day Adventists. Am. J. Clin. Nutr., 48 (3 Suppl), 739–748; Talamini, R. and others, 1986. Nutrition, social factors, and prostate cancer in a northern Italian population. Br. J. Cancer, 53 (6), 817–821; Rose, D.P. and others, 1986. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer, 58 (11), 2263–2271.
508
Newby, J.A. and Howard, 2006. Environmental influences in cancer aetiology, 2006, 1-59.
509
Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
510
БФР (BGH, Bovine Growth Hormone) – бычий фактор (гормон) роста. – Примеч. ред.
511
Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
512
Lawrence R., 1994. Breastfeeding – A Guide to the Medical Profession, Fourth edition. Mossby.
513
Holly, J.M.P., Gunnell, D.J. and Davey Smith, G., 1999. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J. Endocrinol, 162, 321–330.
514
Giudice, L.A., 1992. Insulin-like growth factors and ovarian follicular development. Endocrine Reviews, 13, 641–669.
515
Westlev, B.R. and May, F.E.B., 1994. Role of insulin-like growth factors in steroid modulated proliferation. Journal of Steroid Bioehemistry and Molecular Biology, 51, 1–9; Marcelli, M., Haidacher, S.J., Plymate, S.R. and Birnbaum, R.S., 1995. Altered growth and insulin-like growth factor-binding protein-3 production in PC-3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid. Endocrinology, 136, 1040–1048.
516
Holly, J.M.P., Gunnell, D.J. and Davey Smith, G., 1999. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J. Endocrinol, 162, 321–330.
517
Bernstein, I. and Ross, R.K., 1993. Endogenous hormones and breast cancer risk. Epidemiol Res, 15, 48–65; Pike, M.C. and others, 1993. Estrogens, progestogens, normal breast proliferation and breast cancer risk. Epidemiol Reviews, 15, 17–35.
518
Bocchinfuso, W.F. and others, 2000. Induction of mammary gland development in estrogen receptor-alpha knoclout mice. Endocrinology; 141; 2983–2994; Attwood, C.S. and others, 2000. Progesterone induces side-branching of the ductal epithelium in the mammary glands of prepubertalmice. J. Endocrinology, 167, 39–52.
519
Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Healths. Benbella Books.
520
www.breakthrough.org.uk
521
Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.
522
Cramer, D.W. and others, 1989. Galactose consumption and metabolism in relation to the risk of ovarian cancer Lancet, 2, 66–71.
523
Fairfield and others, 2004. A prospective study of dietary lactose and ovarian cancer. Int J. of Cancer, 110 (2), 271–277.
524
Larsson, S.C. and others, 2004. Milk and lactose intakes and ovarian cancer risk. In the Swedish Mammography Cohort. Amer J. Clinical Nutrition, 80 (5), 1353–1357.
525
Larsson, S.C. and others, 2005. Milk, milk products and lactose intake and ovarian cancer risk: a meta analysis of epidemiological studies. Int J. of Cancer.
526
Ganmaa, D. and Sato, A., 2005. Possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Medical Hypotheses, 65 (6), 1028–1037.
527
Hartman, S. and others, 1998. Natural occurrence of steroid hormones in food. Food Chemistry, 62, 7-20; Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
528
Plant, Jane and Tidey, Gill, 2005. Eating for Better Health. Virgin Books.
529
Bahna, S,L., 1987. Milk allergy in infancy. Ann Allergy. 59, 131.
530
Dunea, G., 1982. Beyond the Etheric. BMJ, 285, 428–429.
531
Kretchmer, N., 1981. The Significance of lactose intolerance. In: Paige, D.M. and Bayless, T.M., Editors., Lactose Digestion: Clinical and nutritional implications. Johns Hopkins University Press.
532
http://www.fda.gov/fdac/features/2001/4 01_food.html
533
http://www.ifst.org/hottop19.htm
534
Taylor, S.L., 1992. Chemistry and detection of food allergens. Food Technology, 46 (5), 146–152.
535
Saarinen, K.N. and others, 2005. Clinical course and prognosis of cow's milk allergy are dependent on milk-specific IgE status. Journal of Allergy and Clinical immunology, 136 (4), 869–875.
536
http://www.ifst.org/hottop19.htm
537
Martin, Peter, 2002. Milk: Nectar or poison? Sunday Times Magazine, July 21. 2002.
538
Thorsdottir, I. and Ramel, A., 2003. Dietary intake of 10– to 16-year-old children and adolescents in Central and Northern Europe and association with the incidence of type-1 diabetes. Annals of Nutrition and Metabolism, 47 (6), 267–275.
539
Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.
540
TB bacteria found in treated milk. Sunday Times, 20 February, 2000.
541
Bull, T.J. and others, 2003. Detection and verification of Mycobactenum avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease, Journal of Clinical Microbiology. 41 (7), 2915–2923.
542
Millar, D. and others, 1996. IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales. Applied and Environmental Microbiology, 62 (9), 3446–3452.
543
Pickup, R.W. and others, 2005. MAP in the catchment area and water of the River Taff in South Wales, UK and its potential relationship to clustering of Crohn's disease cases in the city of Cardiff. Applied and Environmental Microbiology, 71 (4), 2130–2139.
544
FSA/SE, 2001. Task force on E.coli 0157. www.food.gov.uk/mnltimedia/pdfs/ecolitaskfinreport.pdf
545
Джон Кребс – эколог и профессор Оксфордского университета, председатель совета Комитета по пищевым стандартам Великобритании. – Примеч. ред.
546
Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
547
Plant, Jane and Tidey, Gill, 2003. Understanding, Preventing and Overcoming Osteoporosis. London: Virgin Books.
548
Robbins, John, 1987. A Diet for a New America. Stillpoint Publishing.
549
Hegsted D.M., 1986. Calcium and osteoporosis. J. Nutr., 116, 2316–2319.
550
Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.
551
Акне – угревая сыпь. – Примеч. ред.
552
Ademamowo, C.A. and others, 2005. High-school dietary dairy intake and teenage acne. Journal of the American Academy of Dermatology, 52 (2), 207–214.
553
Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
554
Toohey, M.L., and others, 1998. Cardiovascular disease risk factors are lower in African-American vegans compared to lacto-ovo-vegetarians. Journal of the American College of Nutrition, 17 (5), 425–434.
555
Park, M. and others, 2005. Consumption of milk and calcium in mid-life and the future risk of Parkinson disease. Neurology, 64, 1047–1051.
556
World Cancer Research Fund and American Institute for Cancer Research. 1997. Food, Nutrition and the Prevention of Cancer: a Global Perspective. Washington DC: American Institute for Cancer Research (http://www.aicr.org/report2.htm).
557
http://www.pcrm.org/health/Dairy_and_Prostate_Cancer/d_p_article.html
558
Plant, Jane and Tidey, Gill, 2002. The Plant Programme. Paperback edition. Virgin Books; Plant, Jane and Tidey, Gill, 2003. Understanding, Preventing and Overcoming Osteporosis. Virgin Books; Plant, Jane, 2004, updated 2007. Prostate Cancer: Understand, Prevent and Overcome. Virgin Books; Plant, Jane and Tidey, Gill, 2005. Eating for Better Health. Virgin Books.
559
Smith-Warner, S.A. and Giovannucci, E., 1999. Fruit and vegetable intake and cancer. In: Heber, D., Blackburn, G.L. and Go, V.L.W., editors. Nutritional oncology. San Diego: Academic Press. 153–183.
560
American Institute for Cancer Research, 2000. Press Release (August 31, 2000) from the AICR Annual Research Conference 2000: New Methods in Clinical Trials Lending New Insights on Diet-cancer Connection, Expert Says.
561
National Cattlemen's Beef Association, 1999. Conjugated Linoleic Acid and Dietary Beef. An Update. Beef Facts: Nutrition, Series No. FS/N 016.
562
Ip, C., Scimeca, J.A., and Thompson, H.J., 1994. Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer, 74, 1050–1054.
563
Steinhart, Carol, 1996. Conjugated Linoleic Acid: The Good News about Animal Fat. Journal of Chemical Education, 73, A302. http://jchemed.chem.wisc.edu/Journal/Issues/1996/Dec/absA302.html
564
Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China, American Journal of Clinical Nutrition, 59 (Suppl.), 11 535-11 615.
565
Bernstein, L. and Ross, R.K., 1993. Endogenous hormones and breast cancer risk. Epidemiol Reviews, IS, 48–65; Pike and others, 1993. Estrogens, progestogens, normal breast proliferation and breast cancer risk. Epidemiol reviews. 15, 17–35.
566
Prentice. R. and others, 1990. Dietary fat reduction and plasma oestrodial concentration in healthy postmenopausal women. J. Natl Cancer Inst, 82, 129–134.
567
www.mdanderson.org/departments/nutririon/display.cfm/id=51f759d8-98b2-lld5''813300508b603al4&method=displayfull&pn=51f7589e-98b2-lld5-813300508b603al4
568
Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.
569
Campbell, T, Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.
570
Ornish, D and others, 2005. Intensive lifestyle changes may affect the progression of prostate cancer. Journal of Urology, 174 (3), 1065–1069.
571
Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.
572
Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.
573
Plant, Jane and Tidey, Gill, 2005. Eating for Better Health. Virgin Books. See also, Campbell, T, Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Longterm Health. Benbella Books; Robbins, John, 1987. A Diet for a New America . Stillpoint Publishing.
574
Newby, J.A. and Howard, C.V., 2006. Environmental influences in cancer aetiology. Journal of Nutritional and Environmental Medicine, 2006, 1–59.
575
Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. American Journal of Clinical Nutrition, 59 (Suppl.), 11 535-31 615.
576
Food Chemical News, April 29, 1996.
577
Kurzer, M.S. and Xu, X., 1999. Dietary Phytoestrogens. Annual Reviews of Nutrition, 17, 353–381.
578
Adlercreutz, H, 1995. Phyto-oestrogens: Epidemiology and a Possible Role in Cancer Protection. Environmental Health Perspectives, 103 (Suppl. 7), 103–112; Adlercreutz, H., Mazur, W., Bartels, P., Elomaa, V.-V., Watanabe, S., Wahala, K., Landstrom, M., Lundin, E., Bergh, A., Damber, J.-E., Aman, P., Widmark, A., Johansson, A., Zhang, J.-X. and Hallmans, G., 2000. Phytooestrogens and Prostate Disease. J. Nutr., 130, 658S-659S.
579
http://www.ifst.org/hottop34.htm
580
Adlercreutz, H., Mazur, W., Bartels, P., Elomaa, V.-V., Watanabe, S., Wahala, K., Landstrom, M., Lundin, E., Bergh, A., Damber, J.-E., Aman, P., Widmark, A., Johansson, A., Zhang, J.-X. and Hallmans, G., 2000. Phyto-oestrogens and Prostate Disease. J. Nutr., 130, 658S-659S.
581
Zhou, J.-R., Gugger, E.T., Tanaka, T., Guo, Y., Blackburn, G.L. and Clinton, S.K., 1999. Soy-bean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J. Nutr., 129, 1628–1635; Davis, J.N., Singh, B., Bhuiyan, M. and Sarkar, F.H., 1998, Genistein-induced upregulation of p21WAFl, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer, 32, 123–131; The Royal Society, 2000. Endocrine-disrupting chemicals. Document 06/00. The Royal Society; Setchell, K.D.R., 1998. Phyto-oestrogens: the biochemistry, physiology and implications for human health of soy isoflavones, Nutrition, 68, 1333S-1346S.
582
Glenville, Marilyn, 2003. The New Natural Alternatives to HRT. Second edition. Kyle Cathie.
583
Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.
584
Glenville, Marilen, 2003. The New Natural Alternatives to HRT. Second edition. Kyle Cathie.
585
Robbins, John, 1987. A Diet for a New America . Stillpoint Publishing; Kradjian, R.M., 1994. Save Yourself from Breast Cancer. New York: Berkley Books; McDougall, John, 2000. The McDougall Program for Women; Lee, John R., 1999. Natural Progesterone. Second revised edition. Jon Carpenter; Plant, Jane and Tidey; Gill, 2003. Understanding, preventing and overcoming osteoporosis. Virgin Books; Fox, Douglas, 2001. Hard cheese. New Scientist, 15 December 2001, 42–45.
586
http://wayne.unl.edu/00aprilcolumn.htm
587
Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine, July 21, 2002. 46–54.
588
Website of the American Cancer Society, http://www.cancer.org/docroot/eto/content/eto_5_3x_soy-bean.asp?siteare a=&viewmode=print
589
Gottlieb, Scott, 2003. Men should eat nine servings of fruit and vegetables a day. BMJ, 326, 1003.
590
UK Ministry of Agriculture, Fisheries and Food advice as reported in the Sunday Times, 1999.
591
Willet, W.C., 1994. Micronutrients and cancer risk. Am J. Clin. Nutr., 59, (suppl), 1162S-5S. See also: Willett, Walter C., Colditz, Graham A. and Mueller, Nancy A., 1996. Strategies for Minimising Cancer Risk. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 88–95.
592
Huang, M.-T., Asawa T., Ho C.-T., Rosen R.T., eds, 1994. Food phytochemicals for cancer prevention I – fruits and vegetables. Washington, DC: American Chemical Society; Ho, C.-T., Osawa, T., Huang, M.-T. and Rosen, R.T., eds, 1994. Food phytochemicals for cancer prevention II – teas, spices, herbs. Washing ton, DC: American Chemical Society; American Institute for Cancer Research, ed., 1996. Dietary phytochemicals in cancer prevention and treatment. New York: Plenum Press; Liu, R.H. and Espinosa, A., 2000. Bio-active Compounds from Fruits and Vegetables in the Prevention of Cancer. In: Agriculture in the New Century: Managing Bio-Resources and Bio-Diversity, National Taiwan University, Taipei, Taiwan, 53–59.
593
Greenwald, Peter, 2002. Cancer chemoprevention. BMJ, 324, 714–718.
594
Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group, Heinonen, O.P., Huttunen, J.K. and Albanes, D., 1994. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J. Mod, 330, 1029–1035; Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R. and Class, A., 1996. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J. Med, 334, 1150–1355.
595
Ursell, Amanda, 2007. Eat a rainbow to stay healthy. The Times (T2), 6 February, 2007.
596
Gunnell, D L and 10 others, 2003. Are diet – prostate-cancer association mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP– 3 in healthy middle-aged men. British Journal of Cancer, 88; 1682–1686.
597
Mucci, L.A. and six others, 2001. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system. BJU Int. 87, 814–820.
598
http://www.flax.com.fda
599
http://info.cancerresearchuk.org/healthyliving/dietandhealthyeating/theepicstudy
600
Am. J. Epidemiol, 1994. 139 (11), s 37.
601
Inside Story. Which? April 2002, 4.
602
Lu, C. and others, 2006. Organic diets significantly lower children's dietary exposure to organophosphorus pesticides. Environmental Health Perspectives, 114 (2), 260–263.
603
Doll, R. and Peto, R., 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. New York: Oxford University Press.
604
Boseley, Sarah, 2006. Expert revered for painstaking work that proved link between smoking and cancer. Guardian, 8 December, 2006.
605
Colborn, T.T., 1993. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environmental Health Perspectives, 101 (5), 378–384.
606
McKinlay, R. and others, in press. Endocrine-disrupting pesticides: implications for risk assessment.
607
Royal Commission on Environmental Pollution, 2005. Special report, crop spraying and health of residents and bystanders.
608
Mittelstaedt, Martin, 2002. Data point to breast-cancer risk. Globe and Mail, 22 November 2002, A5.
609
McMichael, A.J., 1993. Planetary Overload – Global Environmental Change and the Health of the Species. Cambridge University Press.
610
Royal Commission on Environmental Pollution, 2002. A Short Report on the Environmental Effects of Civil Aircraft in Flight. Royal Commission on Environmental Pollution.
611
Bristow, Amanda, 2002. Which?, April 2002, 22–23.
612
Campbell, T Colin, Campbell, Thomas M. II, 2006. The China Study. Benbella Books; McDougall, J. and others, 1995. Rapid reduction of serum cholesterol and blood pressure by a twelve-day, very low fat, strictly vegetarian diet. J. Am. Coll Nutr., 14, 491–496.
613
ICON. September 2002.
614
http://www.eurocbc.org/page641.html http://www.ciwf.co.uk/Trust/FF/farm_facts_fish_farming.htm
615
Cho, E. and others, 2006. Red meat intake and risk of breast cancer among premenopausal women. Archives of International Medicine, 166, 2253–2259.
616
http://info.cancerresearchuk.org/healthyliving/dietandhealthyeating/theepicstudy
617
JAMA, 1985, 254 (3), 356–357.
618
http://www.prostatepointers.org/cmyers/pf0696.html
619
http://info.cancerresearchuk.org/healthyliving/dietandhealthycating/theepicstudy
620
J. Nat Cancer Inst, 1994, 86 (18), 1409–1415.
621
Am. J. Epidem, 1994, 139 (11), S37.
622
http://www.prostatepointers.org/cmyers/pf0696.html; American Heart Association Cookbook, fifth edition, 1995. New York: Times Books, Random House; Pritikin, Nathan, 1979. The Pritikin Program for Diet and Exercise. New York: Bantam Books; Ornish, D., 1990. Dr Dean Ornish's Program for Reversing Heart Disease. New York: Ballantyne Books.
623
Van de Weyer, Courtney, 2005. Changing diets, changing minds. Sustain.
624
www.annieappleseedproject.org/nutgenprotin.html
625
Van de Wever, Courtnev, 2005. Changing diets, changing minds. Sustain.
626
Trichopoulos, Dimitrios, Li, Frederick P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80–85.
627
Djamgoz, M.B.A. and Isbilen, B., 2006. Dietary compounds as anti-cancer agents: a preliminary evaluation of ion channels and membrane excitability as possible target mechanisms. The Lancet.
628
http://www.findarticles.com/cf_0/m0FKA/5_62/62702338/pl/article.jhtmi?term=turmeric%2C+Liz+Brown
629
Steinmetz, K.A. and Potter, J.D., 1991. Vegetables, fruity and cancer, II. Mechanisms. Cancer Causes Control, 1, 427–442; Lam, L.K.T., Zhang, J., Hasegawa, S. and others, 1994. Inhibition of chemically induced carcinogenesis by citrus liminoids. In: Huang, M-T., Asawa, T., Ho, C-T. and Rosen, R.T., eds. Food phytochemicals for cancer prevention, I – fruits and vegetables. Washington, DC: American Chemical Society, pp, 209–219; Zheng, C.Q., Zhang, J., Kenney, P.M. and Lam, L.K.T., 1994 Stimulation of glutathione S-transfcrase and inhibition of carcinogenesis in mice by celery seed oil constituents. In: Huang, M.-T., Asawa, T., Ho, C.-T. and Rosen, R.T., eds, Food phytochemicals for cancer prevention. I – fruits and vegetables. Washington, DC: American Chemical Society, pp. 230–238.
630
Nakatani, N, 1994. Chemistrv of antioxidants from Labiatae herbs. In: Ho, C.-T., Osawa, T., Huang, M.-T. and Rosen, R.T., eds. Food phytochemicals for cancer prevention, II – teas, spices, herbs. Washington, DC: American Chemical Society, pp. 144–153.
631
Ho, C.-T., Ferraro, T., Chen, Q and others; 1994. Phytochemicals in teas and rosemary and their cancer-preventive properties. In: Ho, C.-T., Osawa, T., Huang, M.-T. and Rosen, R.T., eds. Food phytochemicals for cancer prevention, II – teas, spices, herbs. Washington, DC: American Chemical Society, pp. 2-19.
632
Kikuzaki, H. and Nakatani, N, 1993. Antioxidant effects of some ginger constituents. Journal of Food Science, 58, 1407–1410.
633
Zheng, G.Q., Kenney, P.M. and Lam, L.K.T., 1993. Potential anticarcinogenic natural products isolated from lemongrass oil and galanga root oil. Journal of Agricultural and Food Chemistry, 41, 153–156; Zheng, G.Q., Kenney, P.M. and Lam, L.K.T., 1992. Anethofuran, carvone, and limonene: potential cancer chemopreventive agents from dill weed oil and caraway oil. Planta Medico, 58, 338–341; Zheng, G.Q., Kenney, P.M., Zhang, J. and others, 1993. Chemoprevention of benzo[a]pyrene-induced forestomach cancer in mice by natural phthalides from celery seed oil. Nutr. Cancer, 19, 77–86; Zheng, G.Q., Kenney, P.M. and Lam, L.K.T., 1992. Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. Journal of Natural Products, 55, 999-1003; Zheng, C.Q, Kenney, P.M. And Lam, L.K.T., 1992. Myristicin: a potential cancer chernopreventive agent from parsley leaf oil. J. Agric. Food Chem., 40, 107–110.
634
http://www.pcrm.org/health/Dairy_and_Prostate_Cancer/d_p_article.html; World Cancer Research Fund and American Institute for Cancer Research. 1997. Food, Nutrition and the Prevention of Cancer: a global perspective. Washington DC: American Institute for Cancer Research, (http://www.aicr.org/report2.htm)
635
Journal of the American Diabetic Association, May 2001; http://www.wad-sworth.corn/nutrition_d/special_features/news/nutu1201.html.
636
Thompson, L.U., 1994. Antioxidants and hormone-mediated health benefi ts of whole grains. Critical Reviews in Food Science and Nutrition, 34, 473–497.
637
Thompson, L.U., 1992. Potential health benefi ts of whole grains and their components. Contemp Nutr., 17 (6), 1–2.
638
Elson, C.E. and Yu, S.G., 1994. The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables. J. Nutr., 124, 607–614.
639
Elson, C.E. and Yu, S.G., 1994. The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables. J. Nutr., 124, 607–614.
640
Fox, Douglas, 2002. Bread to blame for plague of pimples. New Scientist, 7, December 2002.
641
http://www.dorway.com/badnews.html
642
http://www.stevia.net; http://www.holisticmed.com/sweet/
643
Pesticide residues found in Indian bottled water. 2003. BMJ, 326, 352.
644
http://www.annieappleseedproject.org/nutgenprotin.html, reporting on a conference on nutritional genomics and proteomics in cancer prevention in September 2002, at the USNIH, Bethesda.
645
Why tea is not so good for you after all. The Times, 9 January 2007.
646
www.diagnose-me.com
647
http://rescarch.kib.ki.se/e-uven/public/51419.html
648
ENDS Report.
649
http://www.vegansociety.com/html/info/info28.html
650
http://www.vegansociety.com
651
Royal College of Physicians, 2002. Nutrition and patients: a doctor's responsibility,
652
http://www.pcrm.org/health/Dairy_and_Prostate_Cancer/d_p_article.html
653
Berger, Abi, 2002. Science commentary: What does zinc do? BMJ, 325, 1062–1063.
654
Hambridge, K. M., Casey, C. E. and Krebs, N. F., 1986. Zinc, In: Trace Elements in Human and Animal Nutrition, Fifth Edition, Mertz, W., Ed. Academic Press, Inc. London.
655
Medical Report: Prostate Cancer. ICON, 2002, 1 (5), 8-10.
656
McCusker. R.H., 1998. Controlling Insulin-Like Growth Factor Activity and the Modulation of Insulin-Like Growth Factor Binding Protein and Receptor Binding. J. Dairy Sci., 81, 1790–1800.
657
Josefson, Deborah, 2002. Popping a multivitamin daily can keep disease at bay. BMJ, 324, 1544.
658
Van de Weyer, C., 2005. Changing diets, changing minds. Sustain.
659
Van de Weyer, C., 2005. Changing diets, changing minds. Sustain.
660
The Lancet, 1976, 880–881.
661
Johnson, C., 1999, Environmental controls in iodine deficiency disorders (IDD), Earthworks, 9 November, p. 3, British Geological Survey.
662
Greenwald, Peter, 1996. Chemoprevention of cancer. Scientific American, September 1996, 96–99.
663
Olivotto, Ivo, Hotter, Abram and Lesperance, Mary, 2002. In Breast Cancer Research and Treatment, http://www.nlm.nih.gov/medlineplus/news/fullstory_10706.html
664
Bender, David A., 2002. Dally doses of multivitamin tablets. BMJ, 325, 173–174.
665
Annals of Internal Medicine, July 1, 2003; http://www.nlm.nih.gov/medlineplus/news/fullstory_13210.html
666
Kmietowicz, Zosia, 2003. Food watchdog warns against high doses of vitamins and minerals. BMJ, 326, 1001.
667
http://www.nlm.nih.gov/medlineplus/news/fullstory_13219.html
668
Gluud, C., 2007. Journal of the American Medical Association, 297, 842; see also Can vitamin supplements do more harm than good? New Scientist, v28, February 2007, 6.
669
Oakley, Godfrey P., 2002. Delaying folic acid fortification of flour. BMJ, 324, 1348–1349.
670
Reynolds, Edward, 2002. Fortification of flour with folic acid. BMJ, 324, 918.
671
Feldman, David, 2002. Pathways of Vitamin D Action to Inhibit Prostate Cancer Cell Growth, www.annieappleseedproject.org/nutgenprotin.html
672
Campbell, T.C, and Campbell, T.M., 2006. The China Study. Benbella Books.
673
http://bioscience.igh.cnrs.fr/2001/v6/d/hansen/2.asp
674
Seol, J.G. and fi ve others, 1998. Telomerase activity in acme myelogenous leukemia: clinical and biological implications. Br. J. Haematology, 100, 156–165; Savoysky, E. and seven others, 1996, Down-regulation of telomerase activity is an early event in the differentiation in HL-60 cells. Biochem. Biophys. Res. Commun., 226, 329–334; Albanell, J. and fi ve others, 1996. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res., 56, 1503–1508.
675
Campbell. T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.
676
Barretto, A.M., Schwartz, G.G., Woofruff, R. and Cramer, S.C., 2000. 5-hydroxyvitamin D-3, the prohormone of 1,25-dihydroxyvitamin D-3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiology Biomarkers & Prevention, 9, 3, 265–270.
677
http://www.rense.com/gencral/dair.htm
678
Spallholz, J.E., Stewart, J.R., 1989. Advances in the role of minerals in immunobiology. Center for Food and Nutrition, Texas Tech University, Lubbock 79409. Biol Trace Elem Res. Mar, 19 (3) 129–151.
679
Gynecologic, 2004, 93, 320–327.
680
Redbook, April, 1989, v172, n6, p. 96 (5).
681
Niki, E., Noguchi, N, Tsuchihashi, H. and others, 1995. Interaction among vitamin C, vitamin E and beta-carotene. Am. J. Clin. Nutr., 62 (Suppl), 1322S-1326S.
682
Craig, Winston J., 2002. Phyiochemicals: Guardians of Our Health, http://www.andrews.edu/NUFS/phyto.html, 03/12/02.
683
New Scientist, August 2006.
684
Следуйте инструкциям изготовителя и не превышайте рекомендуемую дозу. Качество таблеток или жиров зависит от фирмы-производителя.
685
Следуйте инструкциям изготовителя и не превышайте рекомендуемую дозу. Качество таблеток или жиров зависит от фирмы-производителя.
686
Следуйте инструкциям изготовителя и не превышайте рекомендуемую дозу. Качество таблеток или жиров зависит от фирмы-производителя.
687
Anon. 2003. Growing problems: Endocrine disruptors under the spotlight. ENDS Report, 336, 20–23.
688
Vikse, R. and others, 1999. Heterocyclic amines in cooked meat. Tidsskr Nor Laegeforen, 119 (1), 45–49.
689
Skog, K. and others, 1997. Polar and non-polar heterocyclic amines in cooked fi sh and meat products and their corresponding pan residues. Food Chemical Toxicology, 35 (6), 555–565.
690
BMJ, 325, 1250.
691
JAMA, 1985, 254 (3), 356–357.
692
JIFSTAN/NCFST Acrylamide in Food Workshop, 1989. White paper for Working Group 5: Risk Communication. National Research Council, National Academy of Sciences (NRC-NAS). Improving Risk Communication. National Academy Press. Washington DC.
693
Fleck, Fiona, 2002. Experts launch action on staple foods. BMJ, 325, 120; Anon. 2002. Acrylamide dues found in Asparagine. ICON, 1 (6), 24.
694
US Environmental Protection Agency, http://www.epa.gov/ttn/atw/hlthef/acrylami.html
695
http://ntp-server.niehs.nih.gov/htdocs/Chem_H&S/NTP_Chem7/Radian79-06-1.html
696
http://www.nsc.org/library/chemical/Acrylami.htm
697
Anon. 1997. Acrylamide. Toxic Air Contaminant Identifi cation. List Summaries – ARB/SSD/SES. September 1997.
698
Advisory Committee on Hazardous Substances. Sixth Annual Report (2001–2002). Department for Environment, Food and Rural Affairs; The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24.
699
US Environmental Protection Agency, http://www.epa.gov/ttn/atw/hlthef/acrylami.html
700
http://ntp-server.niehs.nih.gov/htdocs/Chem_H&S/NTP_Chemy/Radian79-06-1.html
701
http://www.foodstandards.gov.uk/mi3ltimedia/webpage/acrylamide_study_faq
702
www.cancerresearchuk.org
703
White, Craig A. and Macleod, Una, 2002. ABC of psychological medicine: Cancer. BMJ, 325, 377–380.
704
Walsh, Kiri, King, Michael, Jones, Louise, Tookman, Adrian and Blizzard, Robert, 2002. Spiritual beliefs may affect outcome of bereavement: prospective study. BMJ, 324, 1551–1554.
705
White, Craig A. and Macleod, Una, 2002. ABC of psychological medicine: Cancer. BMJ, 325, 377–380.
706
White, Craig A. and Macleod, Una, 2002. ABC of psychological medicine: Cancer. BMJ, 325, 377–380.
707
White, Craig A. and Macleod, Una, 2002. ABC of psychological medicine: Cancer. BMJ, 325, 377–380.
708
Petticrew, Mark, Bell, Ruth and Hunter, Duncan, 2002. Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ, 325, 1066–1069.
709
Graham, J, Ramirez, A, Love, S, Richards, M and Burgess, C. 2002. Stressful life experiences and risk of relapse of breast cancer: observational cohort study. BMJ, 324, 1420–1422.
710
Beales, D., 2004. Beyond mind-body dualism: implications for patient care. Journal of Holistic Healthcare, 1 (3).
711
Ernst, Edzard (ed.), 2001. The desktop guide to complementary and alternative medicine. Mosby.
712
King, Michael and five others, 2002. Effectiveness of teaching general practitioners skills in brief cognitive behaviour therapy to treat patients with depression: randomised controlled trial. BMJ, 324, 947.
713
http://www.nccn.org/patient_gls/_english/_prostate/
714
European Journal of Cancer, 2003, 39, 1562–1567; quoted in BMJ, 327, 402.
715
Plant, Jane and Stephenson, Janet, in preparation. Breakthrough Anxiety and Depression.
716
Bartram, Thomas, 1998. Bartram's Encyclopedia of Herbal Medicine. London: Robinson.
717
Miller, G H, 1996. Can Active or Passive Smoking Increase Breast Cancer Mortality? Cancer Detect Prevent 20 (5).
718
Mayor, Susan. 2002. Pregnancy and early smoking increases breast cancer risk. BMJ, 325, 12 October 2002, 793.
719
Cancer Epidemiology, Biomarkers and Prevention, July 2003; http://www.nlm.nih.gov/medlineplus/news/fullstory_13352.html
720
Plant, Jane and Tidey, Gill, 2003. Understanding, preventing and overcoming osteoporosis. Virgin Books.
721
Goodman-Gruen, D. and Barrett-Connor, E., 1997. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. American Journal of Epidemiology, 145, 970–976; Kaklamani, V.G., Linos, A., Kaklamani E., Markaki, I. and Mantzoros, C., 1999. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. Journal of Clinical Oncology, 17. 813–817.
722
Colborn, T., Dumanoski, D. and Myers, J.P., 1996. Our Stolen Futures, Dutton, Penguin Books, USA.
723
The Environment Agency, March 2000. Endocrine-disrupting substances in the environment: The Environment Agency's Strategy, The Environment Agency, Bristol, UK.
724
Алармистка (от англ. alarm – тревога, сигнал опасности, сигнал тревоги) – распространительница тревожных (обычно необоснованных) слухов. – Примеч. ред.
725
Miller, W.R. and Sharpe, R.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer, S, 69–96; Plant, J.A. and Davis, D.L., 2003. Breast and prostate cancer: sources and pathways of endocrine-disrupting chemicals (EDCs). In Geology and Health. Skinner, H.C.W. and Berger, A.R. (editors). OUP. 95–99.
726
McKinlay, R. and others, in press. Endocrine disrupting pesticides: implications for risk assessment.
727
Toppari, J., Larsen, J.C., Christiansen, P., Giwercman, A., Grandjean, P., Guillette, L-J., Jr, Jegou, B., Jensen, T.K., Jouannet, P., Keiding, N., Leffers, H., McLachlan, J.A., Meyer, O., Muller, J., Rajpert-De Meyts, E., Scheike, T., Sharpe, R.M., Sumpter, J.S., and Skakkebaek, N.E., 1996. Male reproductive health and environmental xenoestrogens. Environmental Health Perspectives, 104, 741–803.
728
www.cancersupportinternational.com
729
The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24; Annual Reports of the (UK) Chemical Stakeholders Forum, 2002, and The Advisory Committee on Hazardous Substances, 2002; Miller, W.R. And Sharpe, P.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer, 5, 69–96.
730
Charlier, C.C.J., 2002. Determination of organochlorine pesticide residues in the blood of healthy individuals. Clinical Chemistry and Laboratory Medicine, 44, 361–364; WWF, 2003. UK national biomonitoring survey. WWF.
731
MDuffie, H.H., 2005. Host factors and genetic susceptibility: a paradigm of the conundrum of pesticide exposure and cancer associations. Reviews on Environmental Health. 20 (2), 77-101.
732
Mathur, V., 2002. Breast cancer incidence and exposure to pesticides among women originating from Jaipur. Environment International, 28 (5), 331–336; Starek, A., 2003. Estrogen and organochlorine xenoestrogens and breast cancer risk. International Journal of Occupational Medicine and Environmental Health. 16 (2), 113–124.
733
Frigo, D.E., 2004. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway. Carcinogenesis, 25 (Feb), 249–261; Lewis, J.S. and others, 2005. Differential effects of 16-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells. Journal of Molecular Endocrinology, 34, 91-105; Tessier, D.D., 2001. Increased ErbB-2 tyrosinekinase activity, MAPK phosporylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides. Toxicological Sciences. 60 (1), 38–43.
734
Swan S.H. and others, 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives, 113, (8).
735
Kawauchi, H., 2002. Identifi cation of growth hormone in the sea lamprey, an extant representative of a group of the most ancient vertebrates. Endocrinology, 143 (12), 4916–4921; Park, J.I., 2005. Conservation of the heterodimeric glycoprotein hormone subunit family proteins and the LGR signalling system from nematodes to humans. Endocrine Journal, 26 (3), 267–276.
736
Environmental Endocrine Disruptors: A Handbook of Property Data, John Wiley and Sons.
737
Edwards, T.T., 2006. Reproductive dysgenesis in wildlife: a comparative view. International Journal of Andrology, 29 (1), 109–121; Guillette, L.L., 1999. Plasma steroid concentrations and male phallus size in juvenile alligators from seven Florida lakes. General and Comparative Endocrinology, 116(3), 356–372.
738
Colborn, T., Dumanoski, D. and Myers, J.P., 1996. Our Stolen Futures, Dutton, Penguin Books, USA.
739
Webb, S.F., 2000. Risk assessment approaches for Pharmaceuticals. In: International Seminar: Pharmaceuticals in the Environment, Technological Institute, Section on Environmental Technology, Brussels, 2000.
740
Kolpin, D.A., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B. and Buxton, H.T.; 2002. Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in US Streams, 1999–2000: A National Reconnaissance. Environmental Science & Technology, 36, 1202–1211.
741
McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, T.H., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report, http://www.nmenv.state.nm.us/gwb/drugs.html; Morelli, J., 2000. Are Our Medicines Tainting the Environment? http://webmd.lycos.com/content/article/25/1728_58159?
742
McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, T.H., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report, http://www.nmenv.state.nm.us/gwb/drugs.html
743
The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24.
744
Hamburger Umwelt Institute, 1997. Poor Design Practices – gaseous emissions form complex products.
745
Brown, S.K. and Cheng, M., 2000. Volatile Organic Compounds (VOCs) in New Car Interiors. Presented at the 35th International Clean Air & Environment Conference Sydney, 26–30 November 2000.
746
http://www.le.ac.uk/ieh
747
Clapp, R.W. and others, 2005. Environmental and occupational causes of cancer. The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.
748
The Globe and Mail, November 22, 2002, page A5. Data point to breast-cancer risk. By Martin Mittelstaedt.
749
Newby, J.A. and Howard, C.V., 2006. Environmental influences in cancer aetiology. Journal of Nutritional and Environmental Medicine; 2006, 1-59.
750
Clapp, R.W. and others, 2005. Environmental and occupational causes of cancer. The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.
751
Birnbaum, L.S. and Fenton, S.E., 2003. Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives, 11 (4), 389–395.
752
www.obgyn.nct/newsrx/womens_health-Colorectal_Cancer-20001214-7.asp
753
http://info.cancerresearchuk.org/healthyliving/dietandhealthycating/theepicstudy
754
www.ucdmc.ucdavis.edu/ucdhs/health/a-z/06BreastCancer/doc06lowerisk.html
755
Epidem. 1994, 23 (6), 1133–1136.
756
Spurgeon, D., 2006. Vitamin D is associated with a lower risk of cancer. BMJ, 332, 70.
757
Miller, W.R. and Sharpe, R.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer, 5, 69–96.
758
http://cis.nci.nih.gov/fact/3_13.htm
759
Gottlieb, Scott. 2002. Study supports evidence on oral contraception and breast cancer. BMJ, 325, 6 July 2002, 8.
760
Writing Group for the Women's Health Initiative Investigators. 2002. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Journal of the American Medical Association, 288, № 3.
761
Collaborative Group on Hormonal Factors in Breast Cancer, 1997. Breast cancer and hormone replacement therapy. Lancet, 350, 1047–1059.
762
Schairer, C., Lubin, J., Troisi, R., and others, 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA, 283(4), 485–491.
763
www.nih.gov/news/pr/nov2002/nichd-29.htm
764
Ross, R.K., Paganini-Hill, A., Wan, P.C. and others, 2000. Effective hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl Cancer Inst, 92, 328–332. Schairer, C., Lubin, J., Troisi, R. and others. 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA, 283 (4), 485–491.
765
The Times. 15 December 2006.
766
Ernst, E (editor), 2001. The Desktop Guide to Complementary and Alternative Medicine: an evidence based approach. Mosby.
767
Lee, John R, 1999. Natural Progesterone. Second revised edition. Jon Carpenter.
768
Cowan, L.D., Gordis, L., Tonascia, J.A. and Jones, G.S., 1981. Breast cancer incidence in women with a history of progesterone deficiency. Am. J. Epidemiology, 114, 209–217.
769
Hrushesky, W.J.M., 1996. Breast cancer, timing of surgery, and the menstrual cycle: call for prospective trial. J. Women's Health, 5, 555–566.
770
Mohr, P.E., Wang, D.Y., Gregory, W.M., Richards, M.A. and Fentiman, I.S., 1996. Serum progesterone and prognosis in operable breast cancer. British J. Cancer, 73, 1552–1555.
771
Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
772
Dibble, S.L. and others, 2002. Risk factors for ovarian cancer; lesbian and heterosexual women. Oncol Nursing Forum, 29 (1), El-7.
773
Ives, A. and Semmens, J., 2007. Pregnancy after breast cancer: population based study. BMJ, 334, 194.
774
www.cancer.org/docroot/cri/content/cri_2_4_5x_what_happens_after_treatment_5.asp?sitearea=cr
775
http://www.cancer.org/docroot/cri/content/cri_2_6x_can_having_an_abortion_cause_or_contribute_to_breast_cancer.asp
776
http://www.cancer.org/docroot/cri/content/cri_2_6x_can_having_an_abortion_cause_or_contribute_to_breast_cancer.asp
777
www.cspinet.org/new/200206251.html
778
Campbell, T., Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.
779
Kannel W.B. and others, 1961. Factors of risk in the development of coronary heart disease – six year follow up experience. Anna. Internal medi., SS.
780
Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.
781
Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. American Journal of Clinical Nutrition, 59 (Suppl.), 11 535–11 615.
782
Marwick, Charles, 2003. Food industry obfuscates healthy eating message, BMJ, 327, 121.
783
Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006, The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.
784
Schlosser, Eric, 2002. Fast Food Nation. Penguin Books.
785
Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine, 21 July 2002, 46–54.
786
Mercer, Chris, 2007. EU unveils milk shake-up plans, www.foodnavigator.com
787
http://www.cafod.org.uk
788
Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
789
Некоторые ученые также связывают диабет 1-го типа с потреблением коровьего молока младенцами и детьми, особенно с генетической склонностью к диабету.
790
Anon, 2003. UK supports exclusive breast feeding for six months. BMJ, 326, 1052.
791
Laurens, Claire, 2003. Baby milk company fined for advertising direct to consumers. BMJ, 327, 307.
792
Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
793
Atkins, P.J., 2005. Fattening children or fattening farmers? School milk in Britain, 1921–1941. Economic H-58.
794
http://www.nationaldairycouncil.org
795
Kradjian, R.M., 1994. Save Yourself from Breast Cancer. Berkley Books, New York.
796
Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine. 21 July 2002, 46–54.
797
Outwater, J.L. and others, 1997. Dairy Products and Breast Cancer: the IGF-1, estrogen and bGH hypothesis. Mod Hypotheses. 48, 453–461.
798
European Commission, Scientific Committee on Veterinary Measures relating to Public Health. 1999. Report on Public Health Aspects of the Use of Bovine Somatotropin, 15–16 March.
799
Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer. inst., 92, 1472–1489.
800
http://www.milksucks.com/osteo.html
801
New, S.A. and Francis, R.M., 2003. Science in Parliament, 60 (4), 21.
802
Plant, Jane and Tidey, Gill, 2004. Science in Parliament. 61 (1), 28.
803
Kradjian, R.M., 1994. .Save Yourself from Breast Cancer. Berkley Books, New York.
804
New, S.A. and Francis, R.M., 2004. Science in Parliament, 61 (3), 21.
805
Robbins, John, 1987. A Diet for a New America. Stillpoint.
806
В 1962 году Рейчел Карсон написала книгу «Молчаливая весна», в которой призвала ученых, работающих в области сельского хозяйства, и членов правительства отказаться от повсеместного отравления планеты пестицидами, а общественность – изменить отношение к роли человека в природе. Книга основана на научных доказательствах и фактической информации о вреде пестицидов, гербицидов и других опасных химических веществ, которые применялись в промышленности и сельском хозяйстве. – Примеч. ред.
807
www.foodnavigator.com
808
Parry, Vivienne, 2007. It's udder confusion. The Times (Body and Soul). 20 January 2007.
809
Butler, Justine, 2007. Second opinion. The Times (Body and Soul), 27 January 2007.
810
ICON, 2006, issue 4.
811
Bristow, A., 2002. Organic processed food. Which? April 2002, 22–23.
812
Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine, 21 July 2002. 46–54.
813
Bristow, A., 2002. Organic processed food. Which? April 2002, 22–23.
814
Inside Story. Which? April 2002, 4.
815
Clapp, R.W., Howe, K.H, and Jacobs, M.M., 2005. Environmental and occupational causes of cancer, www.sustainableproduction.org
816
Plant, J.A., Turner, K.T., and Highley, D.E., 1998. Minerals and the environment. Proceedings of Minerals '98 Conference, June 1998: Republished in the Mineralogical Society Bulletin, No. 119, July 1998, 3–11; Mineral Planning 77, December 1998, 3–8; IM&M Journal, December 1998, 1, 12, 331–336.
817
Kushi L.H. and others, 2007. Lifestyle factors and survival in women with breast cancer. The Journal of Nutrition, Special supplement; Intern. Research conf. on food, nutrition and cancer, 236S-242S.
818
Getz, Linn, Sigurdsson, Johann A. and Hetlevik, Irene, 2003. Is opportunistic disease prevention in the consultation ethically justifiable? BMJ, 327, 498.
819
Research muddled by political pressures. The Times (Public Agenda), 19 August 2003.
820
Chaturvedi, P., 2003. Medical community may be partly responsible for cancer misery. BMJ, 326, 1146.
821
Kmietowicz, Zosia, 2002. Research spending on cancers doesn't match their death rates. BMJ, 325, 920.
822
Smith, Richard, 2003. Do patients need to read research? BMJ, 326, 3307.
823
Smith, Richard, 2003. Do patients need to read research? BMJ, 326, 1307.
824
Corrie, Pippa, Shaw, Justin and Harris, Roy, 2003. Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study. BMJ, 327, 320–321.
825
Wald, Nicholas J. and Morris, Joan K… 2003. Teleoanalysis: combining data from different types of study. BMJ, 327, 616–618.
826
The Times (Public Agenda), 6 March 2007.
827
Smith, Richard, 2003. Editor's choice: The screening industry. BMJ, 326, 26 April 2003.
828
Lechin, Fuard and others, 2002. Neurocircuitry and Neuroautonomic Disorders. Karger.
829
Gottlieb, Scott, 2003. US drug sales continue to rise. BMJ, 326, 518.
830
Gottlieb, Scott, 2002. Drug companies maintain 'astounding' profits, BMJ, 324, 1054.
831
Kjaergard, Lise L. and Als-Nielsen, Bodily 2002. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ, 325, 249–252.
832
Eaton, Lynn, 2003. Readers want transparency in link between doctors and drug firms. BMJ, 326, 1352.
833
Mayor, Susan, 2002. Researchers claim clinical trials are reported with misleading statistics. BMJ, 324, 1353.
834
JAMA, 2003, 389, 454–465, quoted by Hopkins Tanne, Janice, 2003. Industry is deeply involved in funding US research. BMJ, 326, 179.
835
Tonks, Alison, 2002. Authors of guidelines have strong links with drugs industry. BMJ, 324, 383.
836
Spurgeon, David, 2002. Doctors accept $50 a time to listen to drug representatives. BMJ, 324, 1113.
837
Gottlieb, Scott, 2003. A fifth of Americans contact their doctor as a result of direct to consumer drug advertising. BMJ, 325, 854.
838
BMJ, 2003. Drug companies want to inform patients. BMJ, 326, 1286.
839
Watson, Rory, 2003. EU health ministers reject proposal for limited direct to consumer advertising. BMJ, 326, 1284.
840
Watson, R., 2006. Cancer group denies company funding will influence its agenda. BMJ, 333, 874.
841
Mayor, Susan, 2002. GMC issues new guidance on clinical research. BMJ, 324, 384.
842
Marwick, Charles, 2002. US tackles drug company gifts to doctors. BMJ, 325, 795.
843
Mosconi, Paola, 2003. Declaration of competing interests is rare in Italian breast cancer associations. BMJ, 327, 344.
844
Herxheimer, A., 2003. Relationships between the pharmaceutical industry and patients' organisations. BMJ, 326, 1208–1210.
845
Hirst, J., 2003. Charities and patient groups should declare interests. BMJ, 326, 1211.
846
Clark, Jocalyn, 2003. A hot flush for Big Pharma. BMJ, 327, 400.
847
Writing Group for the Women's Health Initiative Investigators, 2002. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women. JAMA, 288, 321–333.
848
The Times, 15 December 2006.
849
Moynihan, Ray, 2003. US seniors group attacks pharmaceutical industry 'fronts'. BMJ, 326, 351.
850
Cho, E, and others, 2006. Red meat intake and risk of breast cancer among premenopausal women. Archivesof International Medicine, 166, 2253–2259.
851
Lenzer, Jeanne, 2002. The operation was a success (but the patient died). BMJ, 325, 664.
852
Moynihan, Ray, 2003. Blurring the boundaries. BMJ. 326, 1094.
853
The selling of a wonder drug. The Guardian, 29 March 2006.
854
http://en.wikipedia.org/wiki/Trastuzumab.
855
Barrett, A. and others, 2006. How much will Herceptin really cost? BMJ, 333, 118–120.
856
Bartlett, Christopher, Sterne, Jonathan and Egger, Matthias, 2002. What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers. BMJ, 325, 81.
857
http://www.madnessmansion.com/!!jimkc/txt/ambulanc.txt/ http://www.public.asu.edu/!!tadams2/Quotes/Ambulance
858
www.cancersupportinternational.com
859
Campbell, T, Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.
860
Robbins, John, 1987. A Diet for a New America. Stillpoint.
861
Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
862
Рейки – древняя энергетическая система, пришедшая к нам из Тибета, а оттуда распространившаяся на Египет, Древнюю Грецию, Рим, Индию и далее на восток, в Китай и Японию. Рейки было доступно немногим посвященным и сохранялось в строгой тайне. Это древнее знание со временем было почти утеряно и вновь открыто в конце прошлого столетия доктором Микао Усуи в Японии. Цель рейки – помочь организму войти в состояние равновесия-гармонии, чтобы он мог излечиться сам. – Примеч. ред.
863
См. Daniel Cramer 1989, Lancet 2, 66–71.
ТЕЛЕГРАМКанал с обзорами, анонсами новинок и книжными подборками
Книжный Вестник
Бот для удобного поиска книг (если не нашлось на сайте)
Поиск книг
Свежие любовные романы в удобных форматах
Любовные романы
О психологии, саморазвитии и личностном росте
Саморазвитие
Детективы и триллеры, все новинки
Детективы
Фантастика и фэнтези, все новинки
Фантастика
Отборные классические книги
Классика
ВКОНТАКТЕБиблиотека с любовными романами, которая наверняка придётся по вкусу женской части аудитории
Любовные романы
Библиотека с фантастикой и фэнтези, а также смежных жанров
Фантастика
Самые популярные книги в формате фб2
Топ фб2
книги